data_5y3u_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5y3u _Structure_validation_residue.Date_analyzed 2017-11-24 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.4 tp . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.811 0.339 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.2 mm -57.61 -34.88 48.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.327 -173.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -77.25 -18.86 57.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 110.245 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.1 -36.47 16.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.804 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 20.6 t -59.31 -56.98 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.905 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.441 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 99.8 mtt180 -65.79 -36.48 83.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.877 -176.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.42 -7.42 68.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.839 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.552 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.5 t80 -89.46 -56.86 3.09 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 122.692 0.397 . . . . 0.0 110.652 177.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.441 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 49.3 p-90 -81.19 -36.73 29.75 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.327 -175.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.84 -23.58 66.7 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.013 0.37 . . . . 0.0 110.972 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.98 -14.53 31.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.087 0.47 . . . . 0.0 110.968 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -174.262 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.8 tp . . . . . 0 N--CA 1.452 -0.355 0 CA-C-O 121.002 0.43 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.0 mm -59.49 -34.34 54.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.325 -173.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -77.05 -20.38 55.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.146 0.498 . . . . 0.0 110.125 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.77 -35.67 20.59 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.563 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 45.8 t -64.23 -58.39 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.322 177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -69.53 -32.56 71.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.392 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.08 -1.87 70.12 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.722 172.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.563 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 5.2 t80 -92.84 -63.15 1.26 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 122.383 0.273 . . . . 0.0 110.618 171.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -80.35 -25.59 39.15 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -169.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.2 mt -75.5 -18.01 59.95 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 m -91.56 -17.79 25.09 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 113.334 -1.757 . . . . 0.0 111.482 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.0 tp . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 121.106 0.479 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.3 mm -70.93 -31.32 45.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.094 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -78.54 -18.5 54.6 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.511 0.672 . . . . 0.0 109.679 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.95 -35.15 20.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.618 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.559 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 14.1 t -60.84 -56.56 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.135 175.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.484 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 82.6 mtp180 -64.4 -38.74 92.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.635 -176.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.31 -1.6 57.52 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.943 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.559 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.9 t80 -93.9 -58.62 2.2 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 122.539 0.335 . . . . 0.0 111.43 172.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.484 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 63.4 p-90 -80.22 -25.86 39.39 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -170.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.26 -25.02 63.16 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 122.049 0.928 . . . . 0.0 109.105 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.38 -24.58 36.9 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.776 -1.556 . . . . 0.0 111.921 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 . . . . . 0 C--N 1.322 -0.628 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.62 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.1 tp . . . . . 0 N--CA 1.45 -0.436 0 CA-C-O 120.976 0.417 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.6 mm -56.59 -33.22 39.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -172.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -74.87 -23.73 58.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.148 0.499 . . . . 0.0 110.24 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.02 -34.12 19.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.829 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.55 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 21.6 t -60.43 -57.17 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.163 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -66.31 -34.34 77.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.506 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.86 -3.93 69.75 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.725 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.55 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.5 t80 -92.43 -59.81 1.99 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 122.542 0.337 . . . . 0.0 110.976 174.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -81.19 -27.08 35.51 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -171.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.7 mt -77.37 -24.14 50.66 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.9 m -89.7 -5.43 57.05 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.387 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.058 -176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.423 ' O ' HG22 ' A' ' 7' ' ' VAL . 39.8 tp . . . . . 0 N--CA 1.446 -0.638 0 CA-C-O 121.204 0.526 . . . . 0.0 110.366 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.9 mm -70.85 -30.54 42.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.423 -169.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -79.78 -18.7 50.37 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.49 0.662 . . . . 0.0 109.39 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.81 -23.89 25.2 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.326 176.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.6 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 41.3 t -82.48 -58.02 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.868 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -69.19 -37.54 78.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.792 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.44 -3.8 54.91 Favored Glycine 0 C--O 1.227 -0.313 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.593 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.6 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 5.5 t80 -91.13 -63.49 1.26 Allowed 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 174.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -81.06 -25.16 37.3 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -170.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt -76.22 -22.76 54.83 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.6 m -90.12 -11.38 41.4 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 113.355 -1.748 . . . . 0.0 110.553 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.397 179.895 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.4 tp . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.46 0.648 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.4 mm -67.45 -31.45 52.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.256 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -79.54 -18.42 51.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.183 0.516 . . . . 0.0 109.788 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.01 -34.0 22.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.56 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 37.2 t -67.31 -60.5 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.919 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.469 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 61.7 mtp180 -65.74 -36.43 83.55 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.352 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . -74.48 -2.1 62.77 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.894 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.56 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.2 t80 -90.0 -61.18 1.74 Allowed 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 175.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.469 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 40.6 p-90 -77.2 -35.54 55.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.015 -174.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.3 -38.22 89.55 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.2 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -81.28 -13.29 58.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.559 -177.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.849 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.9 tp . . . . . 0 CA--C 1.52 -0.182 0 CA-C-O 121.007 0.432 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.5 mm -61.33 -30.66 48.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.865 -174.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -78.6 -18.48 54.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.283 0.563 . . . . 0.0 110.076 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.88 -39.8 17.83 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.521 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 25.4 t -59.6 -56.96 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.048 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 99.8 mtt180 -69.17 -28.51 66.48 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.84 -9.27 87.02 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.309 173.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.521 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.2 t80 -84.82 -61.78 1.7 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.061 173.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.405 ' HD1' ' O ' ' A' ' 7' ' ' VAL . 44.1 p-90 -80.44 -39.3 28.44 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -171.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 83.5 mt -66.06 -29.14 69.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.622 0.725 . . . . 0.0 110.405 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.67 -17.08 39.68 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.459 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 179.247 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.2 tp . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.791 0.329 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.8 mm -59.9 -33.35 52.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.056 -174.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -74.3 -18.38 60.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.451 0.644 . . . . 0.0 110.008 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.02 -36.54 14.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.058 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.522 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 21.8 t -58.95 -56.64 15.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.214 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -66.73 -33.14 74.97 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.489 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.54 -2.24 74.19 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.74 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.522 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.8 t80 -92.69 -62.6 1.36 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 122.28 0.232 . . . . 0.0 110.729 173.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -80.14 -23.21 41.29 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -169.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.3 -36.61 53.97 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.3 m -72.51 -11.65 60.75 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.219 -1.81 . . . . 0.0 111.278 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.979 177.75 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.5 tp . . . . . 0 N--CA 1.457 -0.113 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.7 mm -56.24 -35.15 41.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.116 0.484 . . . . 0.0 112.156 -174.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -71.28 -22.36 61.97 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.187 0.518 . . . . 0.0 110.116 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.8 -36.19 15.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.473 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.57 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 18.8 t -57.36 -55.73 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.532 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -65.55 -37.8 87.74 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.98 -175.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.19 -2.63 63.0 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.703 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.57 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.2 t80 -91.44 -62.62 1.4 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 122.273 0.229 . . . . 0.0 110.418 174.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 58.9 p-90 -79.0 -26.0 43.3 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -170.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.4 mt -75.85 -33.95 60.04 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 97.8 m -84.27 -4.9 59.14 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 113.483 -1.69 . . . . 0.0 110.893 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.326 -0.455 0 O-C-N 122.106 -0.371 . . . . 0.0 111.525 174.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.2 tp . . . . . 0 N--CA 1.448 -0.532 0 CA-C-O 120.955 0.407 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.9 mm -63.85 -32.27 56.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.625 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 -75.41 -27.16 58.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.196 0.522 . . . . 0.0 109.971 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.76 -26.3 32.0 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.137 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.574 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 24.8 t -72.27 -58.44 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.798 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -65.65 -38.37 89.17 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.685 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.61 -3.22 58.11 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.035 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.574 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.8 t80 -91.11 -63.81 1.21 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -80.96 -26.37 36.66 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -169.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.2 mt -76.55 -25.53 54.16 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.115 0.959 . . . . 0.0 108.623 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.3 m -84.64 -11.34 56.14 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.793 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.253 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.9 tp . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.779 0.323 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.0 mm -59.54 -33.92 53.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -173.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -75.59 -18.31 59.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.241 0.543 . . . . 0.0 110.006 -177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.12 -39.47 13.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.903 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.549 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 22.0 t -57.25 -57.63 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.475 177.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.522 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 81.5 mtp180 -63.8 -42.02 97.79 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.018 -174.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.63 -13.51 63.45 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.964 176.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.549 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.9 t80 -82.47 -59.77 2.42 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 122.365 0.266 . . . . 0.0 110.644 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.522 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 59.1 p-90 -75.91 -33.83 59.91 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.234 -174.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.34 -31.78 73.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.951 0.405 . . . . 0.0 110.619 177.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.2 -4.65 55.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.518 0.675 . . . . 0.0 110.685 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.412 ' HB2' ' HA ' ' A' ' 11' ' ' TRP . 0.3 OUTLIER . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.237 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.7 tp . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 121.001 0.429 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.0 mm -61.67 -31.43 50.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.319 -176.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -76.57 -19.68 57.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.216 0.531 . . . . 0.0 110.042 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.66 -35.86 19.09 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.586 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 36.5 t -63.19 -57.05 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.842 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -69.95 -32.2 70.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.447 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.14 -4.06 62.42 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.522 173.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.586 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.6 t80 -91.89 -63.88 1.19 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 122.562 0.345 . . . . 0.0 110.289 173.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -80.7 -27.7 36.92 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -171.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.8 mt -76.66 -37.04 56.9 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 m -74.76 -9.38 58.5 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.73 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.909 177.086 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.6 tp . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.7 mm -59.69 -32.81 50.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.108 -173.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -77.42 -19.44 56.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.165 0.507 . . . . 0.0 110.15 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.52 -36.39 20.54 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 30.4 t -61.77 -60.92 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.42 -1.264 . . . . 0.0 111.172 175.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.476 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 77.8 mtp180 -63.82 -39.07 93.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.704 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.54 -11.19 68.14 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.148 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.556 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.5 t80 -81.8 -58.78 2.84 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.519 0.328 . . . . 0.0 110.48 178.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.476 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 36.5 p-90 -80.18 -36.58 34.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.079 -0.649 . . . . 0.0 112.294 -174.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.81 -29.8 70.99 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.227 -0.296 . . . . 0.0 111.366 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.0 -10.28 53.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.368 0.604 . . . . 0.0 110.685 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 . . . . . 0 C--N 1.319 -0.717 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.504 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.2 tp . . . . . 0 CA--C 1.521 -0.141 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.4 mm -58.82 -31.28 44.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.131 -174.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -80.22 -19.06 47.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.428 0.632 . . . . 0.0 109.865 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.54 -35.56 15.85 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.028 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 13.8 t -56.18 -56.36 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.113 172.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.445 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 97.7 mtt180 -64.4 -39.04 93.09 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.921 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.47 -3.01 65.06 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.032 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.548 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.7 t80 -89.26 -58.93 2.36 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.445 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 39.3 p-90 -80.02 -37.74 33.47 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.199 -174.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.3 mt -63.33 -27.6 69.43 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.981 0.419 . . . . 0.0 110.669 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.74 -10.3 43.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.107 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.728 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.6 tp . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.0 mm -62.69 -31.59 52.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.225 0.536 . . . . 0.0 111.578 -173.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -77.05 -21.07 55.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.943 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.62 -38.43 17.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.568 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 16.9 t -56.4 -58.49 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.121 176.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.51 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 82.2 mtp180 -62.22 -44.54 96.34 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.88 -175.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.22 -5.19 47.33 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.399 176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.568 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.6 t80 -89.68 -57.72 2.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.41 0.284 . . . . 0.0 110.7 177.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.51 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 52.8 p-90 -78.97 -34.63 44.09 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.916 -174.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.77 -33.35 74.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.882 0.372 . . . . 0.0 111.101 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.08 -6.43 57.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.469 0.652 . . . . 0.0 110.528 -177.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.456 -175.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.2 tp . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 120.974 0.416 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.6 mm -59.23 -32.98 49.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.509 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -74.31 -21.28 59.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.151 0.5 . . . . 0.0 110.125 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.75 -36.63 18.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.926 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 15.8 t -58.92 -56.06 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.025 175.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 84.2 mtp180 -66.17 -34.35 77.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.481 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.21 -1.69 64.72 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.668 174.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.511 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.8 t80 -93.7 -60.9 1.65 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 122.448 0.299 . . . . 0.0 111.273 170.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.409 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 63.3 p-90 -80.26 -23.66 40.63 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -168.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.7 mt -72.79 -25.61 61.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.819 0.819 . . . . 0.0 108.847 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.98 -13.72 58.61 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.415 177.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 . . . . . 0 C--N 1.318 -0.778 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.17 -179.549 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.1 tp . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.3 mm -59.31 -32.08 47.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -76.36 -24.19 54.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.215 0.531 . . . . 0.0 110.056 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.61 -31.9 24.01 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.068 177.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.542 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 18.6 t -63.28 -57.75 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.979 175.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -64.26 -39.78 94.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.118 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . -74.4 -1.9 61.97 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.111 176.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.542 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.8 t80 -90.16 -64.66 1.1 Allowed 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 174.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -80.85 -30.94 35.61 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -171.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.0 mt -74.38 -23.2 58.96 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.879 0.847 . . . . 0.0 109.349 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 9' ' ' GLY . 1.2 m -86.92 -16.7 35.14 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.396 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 . . . . . 0 C--N 1.328 -0.367 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -178.013 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.0 tp . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.145 0.498 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.8 mm -65.73 -32.55 58.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.573 -174.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -76.15 -22.0 55.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.183 0.516 . . . . 0.0 109.687 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.01 -35.62 25.67 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 12.1 t -58.36 -55.17 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.606 173.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -67.09 -37.96 84.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.771 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.11 -2.41 52.96 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.812 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.567 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.3 t80 -91.85 -62.4 1.43 Allowed 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 122.354 0.262 . . . . 0.0 110.507 173.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 56.9 p-90 -80.64 -27.71 37.12 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -171.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -76.26 -20.9 56.94 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.023 0.916 . . . . 0.0 108.81 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -91.02 -10.91 40.51 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 113.5 -1.682 . . . . 0.0 110.884 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 . . . . . 0 C--N 1.327 -0.386 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -175.132 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.0 tp . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.74 0.305 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.2 mm -58.75 -34.62 52.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.313 -173.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -73.14 -19.15 61.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.405 0.621 . . . . 0.0 109.94 -177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.5 -37.88 13.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.073 174.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.531 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 14.4 t -57.52 -58.42 6.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.805 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -61.43 -42.17 98.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.566 -173.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.62 -12.13 77.58 Favored Glycine 0 C--O 1.229 -0.196 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.178 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.531 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.1 t80 -80.09 -59.58 2.66 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 122.355 0.262 . . . . 0.0 110.911 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -80.56 -35.59 34.13 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.016 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.91 -26.57 68.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.668 0.27 . . . . 0.0 111.327 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.06 -15.29 28.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.326 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 . . . . . 0 C--N 1.326 -0.417 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -171.905 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.0 tp . . . . . 0 N--CA 1.462 0.16 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.1 mm -59.06 -30.17 43.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.981 -172.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -78.4 -27.52 46.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.27 0.557 . . . . 0.0 109.806 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.34 -31.5 26.76 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.913 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 6.4 t -58.41 -55.05 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.151 172.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.5 mtp85 -63.31 -41.45 98.93 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.444 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.496 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . -71.08 -6.69 61.13 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.779 176.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.599 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 5.0 t80 -89.13 -59.57 2.19 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.76 -0.22 . . . . 0.0 110.468 176.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 49.1 p-90 -81.58 -34.0 31.28 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -174.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.53 -28.23 64.77 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.342 0.591 . . . . 0.0 109.995 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 9' ' ' GLY . 0.9 OUTLIER -90.61 -9.28 47.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.76 179.09 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.599 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.259 -176.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.761 0.315 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -165.91 161.85 17.88 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.4 tp -80.29 -66.65 0.85 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.811 0.339 . . . . 0.0 111.625 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.2 mm -57.61 -34.88 48.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.327 -173.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -77.25 -18.86 57.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 110.245 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.1 -36.47 16.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.804 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 20.6 t -59.31 -56.98 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.905 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.441 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 99.8 mtt180 -65.79 -36.48 83.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.877 -176.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.42 -7.42 68.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.839 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.552 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.5 t80 -89.46 -56.86 3.09 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 122.692 0.397 . . . . 0.0 110.652 177.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.623 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 49.3 p-90 -81.19 -36.73 29.75 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.327 -175.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.84 -23.58 66.7 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.013 0.37 . . . . 0.0 110.972 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.98 -14.53 31.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.087 0.47 . . . . 0.0 110.968 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -101.22 -44.79 5.56 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -174.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 32.7 mmtp -62.87 -30.59 71.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.663 0.744 . . . . 0.0 109.986 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 p -69.43 118.34 61.35 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.805 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -67.52 118.74 5.82 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.343 2.029 . . . . 0.0 110.85 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.2 pt -114.76 37.4 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.427 0.632 . . . . 0.0 110.856 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -83.95 -24.06 30.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.094 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -61.39 137.82 94.65 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.334 174.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.18 78.79 2.53 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.684 2.256 . . . . 0.0 112.654 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.371 -0.823 . . . . 0.0 109.925 176.25 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 27.1 tp . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 121.285 0.564 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -139.79 172.11 13.25 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.8 tp -77.88 -67.14 0.76 Allowed 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.317 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.0 mm -59.49 -34.34 54.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.325 -173.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -77.05 -20.38 55.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.146 0.498 . . . . 0.0 110.125 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.77 -35.67 20.59 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.563 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 45.8 t -64.23 -58.39 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.322 177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -69.53 -32.56 71.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.392 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.08 -1.87 70.12 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.722 172.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.563 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 5.2 t80 -92.84 -63.15 1.26 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 122.383 0.273 . . . . 0.0 110.618 171.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.539 ' O ' ' HG3' ' A' ' 15' ' ' LYS . 65.3 p-90 -80.35 -25.59 39.15 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -169.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.2 mt -75.5 -18.01 59.95 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 m -91.56 -17.79 25.09 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 113.334 -1.757 . . . . 0.0 111.482 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.67 -56.55 2.31 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 11' ' ' TRP . 67.6 mttt -56.59 -32.96 65.75 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.28 0.562 . . . . 0.0 111.465 -172.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.401 HG23 HG23 ' A' ' 18' ' ' ILE . 2.0 p -60.62 112.97 6.43 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.424 174.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.46 118.41 5.67 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.687 2.258 . . . . 0.0 112.26 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.401 HG23 HG23 ' A' ' 16' ' ' VAL . 26.4 pt -131.83 40.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.364 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -94.01 -21.09 19.39 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.463 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -92.31 154.44 42.92 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -79.75 27.01 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.562 2.175 . . . . 0.0 112.365 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.3 p . . . . . 0 C--O 1.251 1.159 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.909 179.594 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 50.6 tp . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 120.864 0.364 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -83.82 -172.98 4.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.955 0.407 . . . . 0.0 111.381 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.0 tp -82.09 -56.04 4.19 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.225 173.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.3 mm -70.93 -31.32 45.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.094 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -78.54 -18.5 54.6 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.511 0.672 . . . . 0.0 109.679 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.95 -35.15 20.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.618 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.559 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 14.1 t -60.84 -56.56 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.135 175.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.484 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 82.6 mtp180 -64.4 -38.74 92.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.635 -176.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.31 -1.6 57.52 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.943 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.559 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.9 t80 -93.9 -58.62 2.2 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 122.539 0.335 . . . . 0.0 111.43 172.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.484 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 63.4 p-90 -80.22 -25.86 39.39 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -170.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.26 -25.02 63.16 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 122.049 0.928 . . . . 0.0 109.105 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.38 -24.58 36.9 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.776 -1.556 . . . . 0.0 111.921 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -103.34 -36.32 8.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.463 ' C ' ' HD2' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -60.74 -25.96 66.86 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.316 0.579 . . . . 0.0 110.784 -176.407 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.42 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 2.3 p -64.69 112.93 9.02 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.568 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.58 117.07 4.59 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.926 1.751 . . . . 0.0 111.383 177.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.2 pt -93.19 38.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.759 0.79 . . . . 0.0 110.636 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -87.07 -13.78 43.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.469 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -90.89 153.11 45.1 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.61 47.55 1.92 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.763 2.309 . . . . 0.0 111.414 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.246 0.884 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.869 -178.194 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 57.6 tp . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -78.18 164.03 25.3 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.1 tp -86.44 -66.07 0.94 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.976 0.417 . . . . 0.0 111.575 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.6 mm -56.59 -33.22 39.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -172.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -74.87 -23.73 58.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.148 0.499 . . . . 0.0 110.24 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.02 -34.12 19.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.829 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.55 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 21.6 t -60.43 -57.17 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.163 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -66.31 -34.34 77.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.506 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.86 -3.93 69.75 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.725 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.55 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.5 t80 -92.43 -59.81 1.99 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 122.542 0.337 . . . . 0.0 110.976 174.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.515 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 59.8 p-90 -81.19 -27.08 35.51 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -171.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.7 mt -77.37 -24.14 50.66 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.9 m -89.7 -5.43 57.05 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.387 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.03 -45.49 5.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.058 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 33.8 mmtp -57.11 -26.02 59.77 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.946 0.879 . . . . 0.0 109.886 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 p -92.33 116.01 65.74 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.349 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -67.05 117.65 4.96 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.063 1.842 . . . . 0.0 111.204 174.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.5 pt -87.69 31.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.609 0.718 . . . . 0.0 111.524 -175.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -102.46 -10.34 19.47 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.532 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -76.83 138.3 66.05 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.18 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.61 69.76 5.14 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.782 2.321 . . . . 0.0 111.917 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.7 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.538 -178.587 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.516 ' H2 ' HD13 ' A' ' 1' ' ' LEU . 9.4 mp . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.717 0.294 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 60.57 -171.92 0.14 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.276 0.56 . . . . 0.0 111.866 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.423 ' O ' HG22 ' A' ' 7' ' ' VAL . 39.8 tp -90.33 -57.09 2.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.366 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.9 mm -70.85 -30.54 42.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.423 -169.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -79.78 -18.7 50.37 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.49 0.662 . . . . 0.0 109.39 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.81 -23.89 25.2 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.326 176.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.6 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 41.3 t -82.48 -58.02 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.868 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -69.19 -37.54 78.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.792 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.44 -3.8 54.91 Favored Glycine 0 C--O 1.227 -0.313 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.593 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.6 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 5.5 t80 -91.13 -63.49 1.26 Allowed 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 174.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -81.06 -25.16 37.3 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -170.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt -76.22 -22.76 54.83 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.6 m -90.12 -11.38 41.4 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 113.355 -1.748 . . . . 0.0 110.553 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -102.34 -49.89 3.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.397 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.532 ' C ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -66.28 -23.38 66.38 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.168 0.508 . . . . 0.0 110.968 -175.303 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.436 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 4.4 p -62.1 116.87 24.62 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.905 175.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.92 116.68 4.69 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.933 1.755 . . . . 0.0 110.903 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.3 pt -89.76 35.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.812 0.815 . . . . 0.0 110.599 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -105.69 -13.63 15.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.774 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -85.71 148.56 49.08 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.09 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.66 55.6 5.57 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.546 2.164 . . . . 0.0 111.623 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.91 -0.567 . . . . 0.0 109.606 -178.446 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 93.8 mt . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 120.481 0.181 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -121.87 130.14 53.14 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.309 0.576 . . . . 0.0 110.73 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.4 tp -90.05 -54.97 3.8 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.457 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.4 mm -67.45 -31.45 52.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.256 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -79.54 -18.42 51.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.183 0.516 . . . . 0.0 109.788 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.01 -34.0 22.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.56 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 37.2 t -67.31 -60.5 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.919 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.469 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 61.7 mtp180 -65.74 -36.43 83.55 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.352 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . -74.48 -2.1 62.77 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.894 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.56 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.2 t80 -90.0 -61.18 1.74 Allowed 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 175.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.469 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 40.6 p-90 -77.2 -35.54 55.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.015 -174.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.3 -38.22 89.55 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.2 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -81.28 -13.29 58.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.559 -177.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -101.86 -42.24 6.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -60.63 -21.92 63.24 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.412 0.625 . . . . 0.0 110.748 -177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.409 ' H ' HG12 ' A' ' 16' ' ' VAL . 2.6 p -73.7 117.56 61.94 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.453 174.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.403 ' C ' ' H ' ' A' ' 19' ' ' LYS . 32.5 Cg_endo -68.51 118.35 5.59 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.098 1.866 . . . . 0.0 111.026 174.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.0 pt -81.39 40.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.657 0.741 . . . . 0.0 110.999 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 17' ' ' PRO . 57.4 mtpt -99.44 -8.7 24.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.532 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -75.47 146.1 80.33 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.56 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.65 49.26 2.1 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.776 2.317 . . . . 0.0 112.333 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.248 1.016 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.61 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.528 ' H2 ' HD13 ' A' ' 1' ' ' LEU . 7.0 mp . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.5 ' NE ' ' HA ' ' A' ' 2' ' ' ARG . 1.0 OUTLIER -122.47 176.82 5.7 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.486 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.418 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 42.9 tp -85.28 -67.84 0.77 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.007 0.432 . . . . 0.0 111.281 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.5 mm -61.33 -30.66 48.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.865 -174.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -78.6 -18.48 54.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.283 0.563 . . . . 0.0 110.076 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.88 -39.8 17.83 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.521 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 25.4 t -59.6 -56.96 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.048 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 99.8 mtt180 -69.17 -28.51 66.48 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.84 -9.27 87.02 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.309 173.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.521 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.2 t80 -84.82 -61.78 1.7 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.061 173.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.474 ' O ' ' HG3' ' A' ' 15' ' ' LYS . 44.1 p-90 -80.44 -39.3 28.44 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -171.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 83.5 mt -66.06 -29.14 69.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.622 0.725 . . . . 0.0 110.405 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.67 -17.08 39.68 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.459 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -103.46 -40.52 6.32 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -65.65 -24.18 66.96 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.096 0.474 . . . . 0.0 110.939 -176.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 p -58.89 115.7 12.84 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.726 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.9 116.78 4.63 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.978 1.786 . . . . 0.0 111.178 175.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 pt -142.99 41.52 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.584 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -97.95 -15.39 20.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.056 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.684 ' HD2' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -56.84 143.53 69.92 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.222 177.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -88.6 37.35 0.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.951 2.434 . . . . 0.0 112.801 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.44 ' OG ' ' HD3' ' A' ' 20' ' ' ARG . 15.6 m . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.56 -0.733 . . . . 0.0 110.504 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.405 HD23 ' H1 ' ' A' ' 1' ' ' LEU . 1.4 pt? . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 121.144 0.497 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.472 ' HG3' ' H ' ' A' ' 3' ' ' LEU . 17.3 tpt180 -167.11 176.16 7.03 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.472 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 37.2 tp -83.96 -69.02 0.67 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.515 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.8 mm -59.9 -33.35 52.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.056 -174.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -74.3 -18.38 60.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.451 0.644 . . . . 0.0 110.008 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.02 -36.54 14.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.058 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.522 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 21.8 t -58.95 -56.64 15.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.214 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -66.73 -33.14 74.97 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.489 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.54 -2.24 74.19 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.74 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.522 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.8 t80 -92.69 -62.6 1.36 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 122.28 0.232 . . . . 0.0 110.729 173.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -80.14 -23.21 41.29 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -169.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.3 -36.61 53.97 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.3 m -72.51 -11.65 60.75 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.219 -1.81 . . . . 0.0 111.278 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -101.68 -49.21 4.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.979 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.554 ' HD2' ' N ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -63.59 -22.1 66.71 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.998 0.428 . . . . 0.0 111.472 -176.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.554 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 3.7 p -58.49 115.33 11.2 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.055 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.98 119.45 6.44 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.196 1.931 . . . . 0.0 111.019 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.5 pt -87.93 39.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.863 0.839 . . . . 0.0 110.214 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -92.26 -26.4 18.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.231 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -63.64 133.65 95.6 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.637 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -82.8 27.93 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.734 2.29 . . . . 0.0 112.598 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.31 -0.853 . . . . 0.0 109.953 -179.649 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 54.5 tp . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.533 0.206 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' A' ' 2' ' ' ARG . 0.8 OUTLIER -167.79 172.43 9.16 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.448 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 43.5 tp -74.29 -70.1 0.41 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -177.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.7 mm -56.24 -35.15 41.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.116 0.484 . . . . 0.0 112.156 -174.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -71.28 -22.36 61.97 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.187 0.518 . . . . 0.0 110.116 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.8 -36.19 15.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.473 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.57 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 18.8 t -57.36 -55.73 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.532 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -65.55 -37.8 87.74 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.98 -175.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.19 -2.63 63.0 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.703 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.57 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.2 t80 -91.44 -62.62 1.4 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 122.273 0.229 . . . . 0.0 110.418 174.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 58.9 p-90 -79.0 -26.0 43.3 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -170.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.4 mt -75.85 -33.95 60.04 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 97.8 m -84.27 -4.9 59.14 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 113.483 -1.69 . . . . 0.0 110.893 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.2 -38.64 7.6 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.106 -0.371 . . . . 0.0 111.525 174.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.492 ' HD2' ' N ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -68.52 -23.29 64.52 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.328 -177.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.492 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 2.9 p -52.89 114.18 5.51 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.175 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -67.32 116.39 4.18 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.145 1.897 . . . . 0.0 111.863 176.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.2 pt -141.82 38.14 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.354 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -99.28 -22.34 15.64 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.718 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.429 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 26.9 mmm180 -83.08 168.19 24.41 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 20' ' ' ARG . 64.5 Cg_endo -82.5 35.38 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.174 1.916 . . . . 0.0 112.617 -174.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.315 -0.85 . . . . 0.0 111.502 176.703 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 65.7 tp . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 110.838 -0.06 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 1' ' ' LEU . 5.3 mpt_? 71.27 129.81 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 122.038 0.923 . . . . 0.0 111.397 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.2 tp -80.55 -57.79 3.42 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.157 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.9 mm -63.85 -32.27 56.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.625 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 -75.41 -27.16 58.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.196 0.522 . . . . 0.0 109.971 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.76 -26.3 32.0 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.137 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.574 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 24.8 t -72.27 -58.44 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.798 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -65.65 -38.37 89.17 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.685 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.61 -3.22 58.11 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.035 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.574 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.8 t80 -91.11 -63.81 1.21 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.633 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 58.7 p-90 -80.96 -26.37 36.66 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -169.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.2 mt -76.55 -25.53 54.16 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.115 0.959 . . . . 0.0 108.623 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.3 m -84.64 -11.34 56.14 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.793 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -103.12 -38.88 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 44.7 mmtm -56.54 -40.35 74.94 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.376 0.608 . . . . 0.0 110.605 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 p -56.63 111.73 3.64 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.94 171.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.91 117.12 4.98 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.058 1.839 . . . . 0.0 111.31 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.8 pt -93.02 25.43 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.861 0.838 . . . . 0.0 110.387 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -108.54 -13.26 14.87 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.478 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -93.16 149.67 37.86 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.824 177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.6 60.61 5.15 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.781 2.321 . . . . 0.0 112.907 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.249 1.052 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 177.131 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 121.302 0.572 . . . . 0.0 111.337 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.477 ' HG3' ' H ' ' A' ' 3' ' ' LEU . 15.3 tpp180 -127.09 176.35 7.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.477 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 36.9 tp -88.24 -70.46 0.64 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.693 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.0 mm -59.54 -33.92 53.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -173.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -75.59 -18.31 59.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.241 0.543 . . . . 0.0 110.006 -177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.12 -39.47 13.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.903 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.549 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 22.0 t -57.25 -57.63 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.475 177.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.522 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 81.5 mtp180 -63.8 -42.02 97.79 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.018 -174.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.63 -13.51 63.45 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.964 176.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.549 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.9 t80 -82.47 -59.77 2.42 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 122.365 0.266 . . . . 0.0 110.644 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.534 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 59.1 p-90 -75.91 -33.83 59.91 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.234 -174.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.34 -31.78 73.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.951 0.405 . . . . 0.0 110.619 177.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.2 -4.65 55.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.518 0.675 . . . . 0.0 110.685 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.412 ' HB2' ' HA ' ' A' ' 11' ' ' TRP . 0.3 OUTLIER -100.31 -51.65 3.59 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.237 -175.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 33.5 mmtp -59.95 -40.72 89.95 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.244 0.545 . . . . 0.0 110.384 -176.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 p -55.61 116.17 11.29 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.008 175.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.52 118.04 5.04 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.133 1.889 . . . . 0.0 111.283 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.7 pt -131.53 37.54 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.536 0.684 . . . . 0.0 110.928 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -99.92 -71.43 0.7 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.725 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -103.59 133.09 20.47 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.895 173.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.53 50.36 3.37 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.602 2.201 . . . . 0.0 111.739 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.248 1.025 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.191 -177.311 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 5' ' ' HIS . 5.9 mp . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 110.581 -0.155 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.535 ' HG3' ' H ' ' A' ' 3' ' ' LEU . 7.9 tpp180 59.94 -169.34 0.15 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.588 0.355 . . . . 0.0 110.449 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.535 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 43.7 tp -90.65 -67.89 0.82 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.001 0.429 . . . . 0.0 110.947 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.0 mm -61.67 -31.43 50.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.319 -176.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.569 ' HB2' ' O ' ' A' ' 1' ' ' LEU . 35.1 m-70 -76.57 -19.68 57.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.216 0.531 . . . . 0.0 110.042 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.66 -35.86 19.09 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.586 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 36.5 t -63.19 -57.05 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.842 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -69.95 -32.2 70.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.447 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.14 -4.06 62.42 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.522 173.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.586 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.6 t80 -91.89 -63.88 1.19 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 122.562 0.345 . . . . 0.0 110.289 173.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -80.7 -27.7 36.92 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -171.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.8 mt -76.66 -37.04 56.9 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 m -74.76 -9.38 58.5 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.73 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -100.58 -51.66 3.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.909 177.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -60.53 -25.13 65.9 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.946 0.403 . . . . 0.0 111.191 -176.552 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.413 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 4.2 p -63.24 115.34 17.13 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.958 175.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.05 116.97 4.92 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.889 1.726 . . . . 0.0 111.166 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.9 pt -95.03 35.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.812 0.815 . . . . 0.0 110.295 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -110.19 -17.3 13.57 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.077 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -97.47 114.63 65.14 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.605 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -83.93 47.6 2.32 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.673 2.249 . . . . 0.0 112.007 177.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.5 m . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.638 -176.92 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -152.6 169.12 23.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.6 tp -83.27 -70.19 0.58 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.056 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.7 mm -59.69 -32.81 50.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.108 -173.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -77.42 -19.44 56.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.165 0.507 . . . . 0.0 110.15 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.52 -36.39 20.54 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 30.4 t -61.77 -60.92 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.42 -1.264 . . . . 0.0 111.172 175.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.476 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 77.8 mtp180 -63.82 -39.07 93.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.704 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.54 -11.19 68.14 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.148 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.556 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.5 t80 -81.8 -58.78 2.84 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.519 0.328 . . . . 0.0 110.48 178.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.64 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 36.5 p-90 -80.18 -36.58 34.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.079 -0.649 . . . . 0.0 112.294 -174.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.81 -29.8 70.99 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.227 -0.296 . . . . 0.0 111.366 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.0 -10.28 53.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.368 0.604 . . . . 0.0 110.685 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -102.55 -42.86 5.8 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 74.1 mmtt -59.71 -37.51 79.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.184 0.516 . . . . 0.0 110.36 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.6 p -56.31 113.2 5.43 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.438 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.33 118.73 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.522 2.148 . . . . 0.0 111.669 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.2 pt -89.22 44.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.61 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -104.59 0.61 28.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.874 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -90.8 169.45 11.77 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.334 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -86.97 37.15 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.512 2.141 . . . . 0.0 111.845 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.0 p . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.665 -178.859 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -85.84 119.73 26.47 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.2 tp -46.75 -60.82 2.16 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 124.191 0.932 . . . . 0.0 112.901 -170.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.4 mm -58.82 -31.28 44.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.131 -174.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -80.22 -19.06 47.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.428 0.632 . . . . 0.0 109.865 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.54 -35.56 15.85 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.028 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 13.8 t -56.18 -56.36 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.113 172.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.445 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 97.7 mtt180 -64.4 -39.04 93.09 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.921 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.47 -3.01 65.06 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.032 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.548 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.7 t80 -89.26 -58.93 2.36 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.616 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 39.3 p-90 -80.02 -37.74 33.47 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.199 -174.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.3 mt -63.33 -27.6 69.43 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.981 0.419 . . . . 0.0 110.669 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.74 -10.3 43.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.107 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -102.2 -42.18 6.13 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 74.7 mmtt -54.81 -39.47 68.53 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.761 0.791 . . . . 0.0 109.777 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.3 p -67.54 116.73 40.37 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.627 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -67.52 117.57 4.95 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.719 1.613 . . . . 0.0 110.392 173.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.3 pt -84.23 36.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.755 0.788 . . . . 0.0 111.564 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -110.49 -10.73 14.54 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.505 173.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -98.5 145.59 30.13 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.882 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.71 52.95 2.63 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.39 2.06 . . . . 0.0 111.419 171.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.559 178.39 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.93 0.395 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -107.01 161.51 14.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.783 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.6 tp -63.58 -63.85 1.06 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -173.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.0 mm -62.69 -31.59 52.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.225 0.536 . . . . 0.0 111.578 -173.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -77.05 -21.07 55.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.943 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.62 -38.43 17.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.568 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 16.9 t -56.4 -58.49 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.121 176.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.51 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 82.2 mtp180 -62.22 -44.54 96.34 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.88 -175.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.22 -5.19 47.33 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.399 176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.568 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.6 t80 -89.68 -57.72 2.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.41 0.284 . . . . 0.0 110.7 177.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.646 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 52.8 p-90 -78.97 -34.63 44.09 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.916 -174.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.77 -33.35 74.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.882 0.372 . . . . 0.0 111.101 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.08 -6.43 57.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.469 0.652 . . . . 0.0 110.528 -177.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.19 -45.64 5.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.456 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 70.9 mmtt -65.75 -34.6 78.55 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.248 0.547 . . . . 0.0 110.414 -176.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -56.55 115.03 8.93 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.969 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.9 118.48 5.64 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.285 1.99 . . . . 0.0 111.216 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.6 pt -111.43 35.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.59 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -83.76 -53.77 5.38 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.05 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -71.88 117.19 55.64 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.416 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.05 43.48 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.614 2.209 . . . . 0.0 111.825 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.468 -0.777 . . . . 0.0 110.756 179.5 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 121.022 0.439 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.462 ' HG3' ' H ' ' A' ' 3' ' ' LEU . 22.8 tpt180 -152.74 173.95 14.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.462 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 42.2 tp -76.33 -65.62 0.9 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.974 0.416 . . . . 0.0 111.114 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.6 mm -59.23 -32.98 49.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.509 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -74.31 -21.28 59.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.151 0.5 . . . . 0.0 110.125 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.75 -36.63 18.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.926 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 15.8 t -58.92 -56.06 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.025 175.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 84.2 mtp180 -66.17 -34.35 77.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.481 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.21 -1.69 64.72 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.668 174.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.511 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.8 t80 -93.7 -60.9 1.65 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 122.448 0.299 . . . . 0.0 111.273 170.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.409 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 63.3 p-90 -80.26 -23.66 40.63 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -168.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.7 mt -72.79 -25.61 61.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.819 0.819 . . . . 0.0 108.847 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.98 -13.72 58.61 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.415 177.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -101.77 -48.04 4.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.17 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -62.8 -25.11 68.07 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.964 0.411 . . . . 0.0 111.176 -177.457 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.427 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 3.4 p -60.37 117.55 25.45 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.194 177.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -67.22 117.02 4.5 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.313 2.009 . . . . 0.0 111.268 175.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.4 pt -124.73 28.02 2.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.562 0.696 . . . . 0.0 110.761 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -109.26 -62.56 1.47 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.729 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -101.82 128.3 29.12 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.657 171.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -83.14 32.81 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.792 2.328 . . . . 0.0 112.673 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.251 1.183 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.473 178.874 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.532 HD13 ' H3 ' ' A' ' 1' ' ' LEU . 6.7 mp . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 121.098 0.475 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.461 ' HA ' ' HE ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -141.34 151.23 43.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.1 tp -57.41 -64.13 0.99 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.3 mm -59.31 -32.08 47.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -76.36 -24.19 54.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.215 0.531 . . . . 0.0 110.056 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.61 -31.9 24.01 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.068 177.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.542 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 18.6 t -63.28 -57.75 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.979 175.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -64.26 -39.78 94.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.118 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . -74.4 -1.9 61.97 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.111 176.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.542 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.8 t80 -90.16 -64.66 1.1 Allowed 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 174.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -80.85 -30.94 35.61 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -171.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.0 mt -74.38 -23.2 58.96 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.879 0.847 . . . . 0.0 109.349 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 9' ' ' GLY . 1.2 m -86.92 -16.7 35.14 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.396 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -100.38 -58.36 1.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HZ1' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -65.35 -21.38 66.69 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -172.503 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.5 p -46.14 112.29 1.72 Allowed Pre-proline 0 C--N 1.322 -0.608 0 O-C-N 124.19 0.931 . . . . 0.0 112.003 177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -65.2 119.41 6.43 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.382 2.055 . . . . 0.0 111.637 175.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.9 pt -92.08 46.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.318 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -101.71 0.77 36.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.58 0.705 . . . . 0.0 110.012 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.448 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 1.7 mmp_? -61.43 163.75 10.67 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.491 175.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -72.31 43.25 0.6 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.686 2.257 . . . . 0.0 112.181 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.421 ' H ' ' C ' ' A' ' 20' ' ' ARG . 8.4 t . . . . . 0 C--O 1.248 1.026 0 C-N-CA 123.501 0.721 . . . . 0.0 110.342 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.788 0.327 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -102.57 144.66 30.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.477 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.0 tp -89.78 -59.95 2.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.748 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.8 mm -65.73 -32.55 58.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.573 -174.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -76.15 -22.0 55.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.183 0.516 . . . . 0.0 109.687 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.01 -35.62 25.67 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 12.1 t -58.36 -55.17 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.606 173.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -67.09 -37.96 84.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.771 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.11 -2.41 52.96 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.812 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.567 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.3 t80 -91.85 -62.4 1.43 Allowed 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 122.354 0.262 . . . . 0.0 110.507 173.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.581 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 56.9 p-90 -80.64 -27.71 37.12 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -171.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -76.26 -20.9 56.94 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.023 0.916 . . . . 0.0 108.81 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -91.02 -10.91 40.51 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 113.5 -1.682 . . . . 0.0 110.884 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -101.79 -50.61 3.64 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 30.9 mmtp -57.79 -40.67 80.41 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.489 0.662 . . . . 0.0 110.483 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 p -58.28 119.19 33.34 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.361 175.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -63.26 118.92 5.82 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.998 1.799 . . . . 0.0 110.589 171.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.4 pt -124.38 45.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.778 -176.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -79.12 -30.82 43.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.121 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -91.86 152.15 42.77 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.244 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.77 32.21 0.51 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.593 2.195 . . . . 0.0 112.047 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.413 -178.038 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.47 HD11 ' H1 ' ' A' ' 1' ' ' LEU . 10.7 mp . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.865 0.364 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.456 ' HG3' ' H ' ' A' ' 3' ' ' LEU . 15.8 tpp180 -152.33 176.12 11.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.456 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 44.0 tp -83.02 -70.01 0.59 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.682 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.2 mm -58.75 -34.62 52.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.313 -173.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -73.14 -19.15 61.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.405 0.621 . . . . 0.0 109.94 -177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.5 -37.88 13.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.073 174.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.531 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 14.4 t -57.52 -58.42 6.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.805 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -61.43 -42.17 98.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.566 -173.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.62 -12.13 77.58 Favored Glycine 0 C--O 1.229 -0.196 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.178 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.531 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.1 t80 -80.09 -59.58 2.66 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 122.355 0.262 . . . . 0.0 110.911 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.489 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 46.6 p-90 -80.56 -35.59 34.13 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.016 -173.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.91 -26.57 68.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.668 0.27 . . . . 0.0 111.327 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.06 -15.29 28.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.326 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -100.47 -54.17 2.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -171.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 0.3 OUTLIER -59.58 -33.92 72.06 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.427 0.632 . . . . 0.0 110.207 -174.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.82 111.94 5.78 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.142 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -70.18 117.53 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.866 1.711 . . . . 0.0 111.167 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.3 pt -93.13 53.66 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.668 0.747 . . . . 0.0 110.11 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HB3' ' HZ1' ' A' ' 19' ' ' LYS . 7.9 mtpm? -110.42 -16.87 13.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.7 -174.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -88.68 130.27 45.76 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.456 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -88.26 30.12 0.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.825 2.35 . . . . 0.0 111.514 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.6 p . . . . . 0 C--O 1.249 1.076 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.838 -178.202 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.3 pp . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 120.665 0.269 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -144.71 127.3 16.08 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.0 tp -50.95 -62.5 1.57 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -168.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.1 mm -59.06 -30.17 43.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.981 -172.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -78.4 -27.52 46.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.27 0.557 . . . . 0.0 109.806 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.34 -31.5 26.76 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.913 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 6.4 t -58.41 -55.05 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.151 172.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.5 mtp85 -63.31 -41.45 98.93 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.444 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.496 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . -71.08 -6.69 61.13 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.779 176.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.599 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 5.0 t80 -89.13 -59.57 2.19 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.76 -0.22 . . . . 0.0 110.468 176.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.541 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 49.1 p-90 -81.58 -34.0 31.28 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -174.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.53 -28.23 64.77 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.342 0.591 . . . . 0.0 109.995 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 9' ' ' GLY . 0.9 OUTLIER -90.61 -9.28 47.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.76 179.09 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.599 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -94.38 -56.14 2.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.259 -176.121 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 70.6 mmtt -63.71 -30.82 71.87 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.036 -172.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 p -63.53 113.81 11.02 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.024 175.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -69.46 116.84 4.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.92 1.746 . . . . 0.0 110.628 174.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 pt -111.48 31.72 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.516 0.674 . . . . 0.0 111.788 -174.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm -101.53 -30.78 11.21 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.097 174.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -75.3 148.02 83.23 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.104 174.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.86 47.95 2.49 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.468 2.112 . . . . 0.0 111.424 171.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 C--O 1.252 1.184 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.834 -176.937 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.4 tp . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.811 0.339 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.2 mm -57.61 -34.88 48.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.327 -173.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -77.25 -18.86 57.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 110.245 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.1 -36.47 16.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.804 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 20.6 t -59.31 -56.98 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.905 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.442 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 99.8 mtt180 -65.79 -36.48 83.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.877 -176.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.42 -7.42 68.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.839 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.552 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.5 t80 -89.46 -56.86 3.09 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 122.692 0.397 . . . . 0.0 110.652 177.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.442 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 49.3 p-90 -81.19 -36.73 29.75 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.327 -175.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.84 -23.58 66.7 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.013 0.37 . . . . 0.0 110.972 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.98 -14.53 31.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.087 0.47 . . . . 0.0 110.968 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -174.262 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.8 tp . . . . . 0 N--CA 1.452 -0.355 0 CA-C-O 121.002 0.43 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.0 mm -59.49 -34.34 54.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.325 -173.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -77.05 -20.38 55.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.146 0.498 . . . . 0.0 110.125 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.77 -35.67 20.59 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.563 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 45.8 t -64.23 -58.39 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.322 177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -69.53 -32.56 71.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.392 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.08 -1.87 70.12 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.722 172.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.563 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 5.2 t80 -92.84 -63.15 1.26 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 122.383 0.273 . . . . 0.0 110.618 171.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -80.35 -25.59 39.15 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -169.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.2 mt -75.5 -18.01 59.95 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 m -91.56 -17.79 25.09 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 113.334 -1.757 . . . . 0.0 111.482 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.063 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.0 tp . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 121.106 0.479 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.3 mm -70.93 -31.32 45.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.094 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -78.54 -18.5 54.6 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.511 0.672 . . . . 0.0 109.679 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.95 -35.15 20.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.618 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.562 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 14.1 t -60.84 -56.56 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.135 175.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.482 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 82.6 mtp180 -64.4 -38.74 92.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.635 -176.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.31 -1.6 57.52 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.943 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.562 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.9 t80 -93.9 -58.62 2.2 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 122.539 0.335 . . . . 0.0 111.43 172.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.482 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 63.4 p-90 -80.22 -25.86 39.39 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -170.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.26 -25.02 63.16 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 122.049 0.928 . . . . 0.0 109.105 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.38 -24.58 36.9 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.776 -1.556 . . . . 0.0 111.921 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 . . . . . 0 C--N 1.322 -0.628 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.62 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.1 tp . . . . . 0 N--CA 1.45 -0.436 0 CA-C-O 120.976 0.417 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.6 mm -56.59 -33.22 39.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -172.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -74.87 -23.73 58.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.148 0.499 . . . . 0.0 110.24 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.02 -34.12 19.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.829 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 21.6 t -60.43 -57.17 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.163 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -66.31 -34.34 77.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.506 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.86 -3.93 69.75 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.725 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.554 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.5 t80 -92.43 -59.81 1.99 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 122.542 0.337 . . . . 0.0 110.976 174.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -81.19 -27.08 35.51 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -171.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.7 mt -77.37 -24.14 50.66 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.9 m -89.7 -5.43 57.05 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.387 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.058 -176.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 7' ' ' VAL . 39.8 tp . . . . . 0 N--CA 1.446 -0.638 0 CA-C-O 121.204 0.526 . . . . 0.0 110.366 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.9 mm -70.85 -30.54 42.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.423 -169.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -79.78 -18.7 50.37 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.49 0.662 . . . . 0.0 109.39 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.81 -23.89 25.2 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.326 176.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.601 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 41.3 t -82.48 -58.02 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.868 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -69.19 -37.54 78.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.792 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.44 -3.8 54.91 Favored Glycine 0 C--O 1.227 -0.313 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.593 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.601 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 5.5 t80 -91.13 -63.49 1.26 Allowed 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 174.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -81.06 -25.16 37.3 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -170.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt -76.22 -22.76 54.83 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.6 m -90.12 -11.38 41.4 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 113.355 -1.748 . . . . 0.0 110.553 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.397 179.895 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.4 tp . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.46 0.648 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.4 mm -67.45 -31.45 52.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.256 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -79.54 -18.42 51.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.183 0.516 . . . . 0.0 109.788 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.01 -34.0 22.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.56 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 37.2 t -67.31 -60.5 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.919 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.473 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 61.7 mtp180 -65.74 -36.43 83.55 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.352 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.48 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . -74.48 -2.1 62.77 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.894 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.56 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.2 t80 -90.0 -61.18 1.74 Allowed 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 175.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.473 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 40.6 p-90 -77.2 -35.54 55.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.015 -174.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.3 -38.22 89.55 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.2 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -81.28 -13.29 58.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.559 -177.111 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.849 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.9 tp . . . . . 0 CA--C 1.52 -0.182 0 CA-C-O 121.007 0.432 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.5 mm -61.33 -30.66 48.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.865 -174.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -78.6 -18.48 54.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.283 0.563 . . . . 0.0 110.076 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.88 -39.8 17.83 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 25.4 t -59.6 -56.96 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.048 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 99.8 mtt180 -69.17 -28.51 66.48 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.84 -9.27 87.02 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.309 173.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.517 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.2 t80 -84.82 -61.78 1.7 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.061 173.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 44.1 p-90 -80.44 -39.3 28.44 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -171.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 83.5 mt -66.06 -29.14 69.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.622 0.725 . . . . 0.0 110.405 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.67 -17.08 39.68 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.459 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 179.247 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.2 tp . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.791 0.329 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.8 mm -59.9 -33.35 52.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.056 -174.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -74.3 -18.38 60.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.451 0.644 . . . . 0.0 110.008 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.02 -36.54 14.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.058 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.524 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 21.8 t -58.95 -56.64 15.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.214 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -66.73 -33.14 74.97 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.489 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.54 -2.24 74.19 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.74 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.524 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.8 t80 -92.69 -62.6 1.36 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 122.28 0.232 . . . . 0.0 110.729 173.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -80.14 -23.21 41.29 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -169.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.3 -36.61 53.97 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.3 m -72.51 -11.65 60.75 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.219 -1.81 . . . . 0.0 111.278 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.979 177.75 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.5 tp . . . . . 0 N--CA 1.457 -0.113 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.7 mm -56.24 -35.15 41.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.116 0.484 . . . . 0.0 112.156 -174.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -71.28 -22.36 61.97 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.187 0.518 . . . . 0.0 110.116 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.8 -36.19 15.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.473 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.572 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 18.8 t -57.36 -55.73 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.532 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -65.55 -37.8 87.74 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.98 -175.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.19 -2.63 63.0 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.703 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.572 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.2 t80 -91.44 -62.62 1.4 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 122.273 0.229 . . . . 0.0 110.418 174.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 58.9 p-90 -79.0 -26.0 43.3 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -170.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.4 mt -75.85 -33.95 60.04 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 97.8 m -84.27 -4.9 59.14 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 113.483 -1.69 . . . . 0.0 110.893 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 C--N 1.326 -0.455 0 O-C-N 122.106 -0.371 . . . . 0.0 111.525 174.238 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.2 tp . . . . . 0 N--CA 1.448 -0.532 0 CA-C-O 120.955 0.407 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.9 mm -63.85 -32.27 56.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.625 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 -75.41 -27.16 58.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.196 0.522 . . . . 0.0 109.971 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.76 -26.3 32.0 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.137 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.577 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 24.8 t -72.27 -58.44 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.798 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -65.65 -38.37 89.17 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.685 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.61 -3.22 58.11 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.035 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.577 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.8 t80 -91.11 -63.81 1.21 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -80.96 -26.37 36.66 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -169.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.2 mt -76.55 -25.53 54.16 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.115 0.959 . . . . 0.0 108.623 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.3 m -84.64 -11.34 56.14 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.793 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.253 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.9 tp . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.779 0.323 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.0 mm -59.54 -33.92 53.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -173.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -75.59 -18.31 59.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.241 0.543 . . . . 0.0 110.006 -177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.12 -39.47 13.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.903 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 22.0 t -57.25 -57.63 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.475 177.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.528 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 81.5 mtp180 -63.8 -42.02 97.79 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.018 -174.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.63 -13.51 63.45 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.964 176.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.552 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.9 t80 -82.47 -59.77 2.42 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 122.365 0.266 . . . . 0.0 110.644 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.528 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 59.1 p-90 -75.91 -33.83 59.91 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.234 -174.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.34 -31.78 73.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.951 0.405 . . . . 0.0 110.619 177.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -91.2 -4.65 55.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.518 0.675 . . . . 0.0 110.685 -179.054 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 11' ' ' TRP . 0.3 OUTLIER . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.237 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.7 tp . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 121.001 0.429 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.0 mm -61.67 -31.43 50.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.319 -176.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -76.57 -19.68 57.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.216 0.531 . . . . 0.0 110.042 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.66 -35.86 19.09 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.586 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 36.5 t -63.19 -57.05 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.842 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -69.95 -32.2 70.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.447 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.14 -4.06 62.42 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.522 173.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.586 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.6 t80 -91.89 -63.88 1.19 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 122.562 0.345 . . . . 0.0 110.289 173.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -80.7 -27.7 36.92 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -171.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.8 mt -76.66 -37.04 56.9 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 m -74.76 -9.38 58.5 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.73 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.909 177.086 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.6 tp . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.7 mm -59.69 -32.81 50.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.108 -173.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -77.42 -19.44 56.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.165 0.507 . . . . 0.0 110.15 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.52 -36.39 20.54 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 30.4 t -61.77 -60.92 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.42 -1.264 . . . . 0.0 111.172 175.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.48 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 77.8 mtp180 -63.82 -39.07 93.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.704 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.54 -11.19 68.14 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.148 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.557 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.5 t80 -81.8 -58.78 2.84 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.519 0.328 . . . . 0.0 110.48 178.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.48 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 36.5 p-90 -80.18 -36.58 34.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.079 -0.649 . . . . 0.0 112.294 -174.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.81 -29.8 70.99 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.227 -0.296 . . . . 0.0 111.366 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.0 -10.28 53.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.368 0.604 . . . . 0.0 110.685 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 . . . . . 0 C--N 1.319 -0.717 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.504 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.2 tp . . . . . 0 CA--C 1.521 -0.141 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.4 mm -58.82 -31.28 44.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.131 -174.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -80.22 -19.06 47.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.428 0.632 . . . . 0.0 109.865 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.54 -35.56 15.85 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.028 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.55 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 13.8 t -56.18 -56.36 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.113 172.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.441 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 97.7 mtt180 -64.4 -39.04 93.09 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.921 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.47 -3.01 65.06 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.032 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.55 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.7 t80 -89.26 -58.93 2.36 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.441 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 39.3 p-90 -80.02 -37.74 33.47 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.199 -174.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.3 mt -63.33 -27.6 69.43 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.981 0.419 . . . . 0.0 110.669 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.74 -10.3 43.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.107 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.728 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.6 tp . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.0 mm -62.69 -31.59 52.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.225 0.536 . . . . 0.0 111.578 -173.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -77.05 -21.07 55.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.943 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.62 -38.43 17.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 16.9 t -56.4 -58.49 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.121 176.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.507 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 82.2 mtp180 -62.22 -44.54 96.34 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.88 -175.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.22 -5.19 47.33 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.399 176.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.569 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.6 t80 -89.68 -57.72 2.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.41 0.284 . . . . 0.0 110.7 177.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.507 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 52.8 p-90 -78.97 -34.63 44.09 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.916 -174.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.77 -33.35 74.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.882 0.372 . . . . 0.0 111.101 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.08 -6.43 57.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.469 0.652 . . . . 0.0 110.528 -177.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.456 -175.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.2 tp . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 120.974 0.416 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.6 mm -59.23 -32.98 49.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.509 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -74.31 -21.28 59.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.151 0.5 . . . . 0.0 110.125 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.75 -36.63 18.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.926 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.508 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 15.8 t -58.92 -56.06 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.025 175.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.404 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 84.2 mtp180 -66.17 -34.35 77.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.481 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.21 -1.69 64.72 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.668 174.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.508 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.8 t80 -93.7 -60.9 1.65 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 122.448 0.299 . . . . 0.0 111.273 170.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.404 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 63.3 p-90 -80.26 -23.66 40.63 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -168.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.7 mt -72.79 -25.61 61.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.819 0.819 . . . . 0.0 108.847 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.98 -13.72 58.61 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.415 177.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 . . . . . 0 C--N 1.318 -0.778 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.17 -179.549 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.1 tp . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.3 mm -59.31 -32.08 47.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -76.36 -24.19 54.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.215 0.531 . . . . 0.0 110.056 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.61 -31.9 24.01 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.068 177.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.544 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 18.6 t -63.28 -57.75 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.979 175.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -64.26 -39.78 94.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.118 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.416 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . -74.4 -1.9 61.97 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.111 176.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.544 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.8 t80 -90.16 -64.66 1.1 Allowed 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 174.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -80.85 -30.94 35.61 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -171.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.0 mt -74.38 -23.2 58.96 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.879 0.847 . . . . 0.0 109.349 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 9' ' ' GLY . 1.2 m -86.92 -16.7 35.14 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.396 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 . . . . . 0 C--N 1.328 -0.367 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -178.013 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.0 tp . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.145 0.498 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.8 mm -65.73 -32.55 58.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.573 -174.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -76.15 -22.0 55.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.183 0.516 . . . . 0.0 109.687 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.01 -35.62 25.67 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.568 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 12.1 t -58.36 -55.17 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.606 173.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -67.09 -37.96 84.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.771 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.11 -2.41 52.96 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.812 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.568 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.3 t80 -91.85 -62.4 1.43 Allowed 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 122.354 0.262 . . . . 0.0 110.507 173.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 56.9 p-90 -80.64 -27.71 37.12 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -171.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -76.26 -20.9 56.94 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.023 0.916 . . . . 0.0 108.81 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -91.02 -10.91 40.51 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 113.5 -1.682 . . . . 0.0 110.884 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 . . . . . 0 C--N 1.327 -0.386 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -175.132 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.0 tp . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.74 0.305 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.409 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 25.2 mm -58.75 -34.62 52.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.313 -173.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -73.14 -19.15 61.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.405 0.621 . . . . 0.0 109.94 -177.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.5 -37.88 13.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.073 174.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.533 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 14.4 t -57.52 -58.42 6.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.805 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -61.43 -42.17 98.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.566 -173.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.62 -12.13 77.58 Favored Glycine 0 C--O 1.229 -0.196 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.178 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.533 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.1 t80 -80.09 -59.58 2.66 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 122.355 0.262 . . . . 0.0 110.911 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -80.56 -35.59 34.13 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.016 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.91 -26.57 68.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.668 0.27 . . . . 0.0 111.327 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.06 -15.29 28.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.326 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 . . . . . 0 C--N 1.326 -0.417 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -171.905 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.0 tp . . . . . 0 N--CA 1.462 0.16 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.1 mm -59.06 -30.17 43.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.981 -172.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -78.4 -27.52 46.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.27 0.557 . . . . 0.0 109.806 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.34 -31.5 26.76 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.913 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 6.4 t -58.41 -55.05 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.151 172.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.5 mtp85 -63.31 -41.45 98.93 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.444 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.502 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . -71.08 -6.69 61.13 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.779 176.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.596 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 5.0 t80 -89.13 -59.57 2.19 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.76 -0.22 . . . . 0.0 110.468 176.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 49.1 p-90 -81.58 -34.0 31.28 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -174.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.53 -28.23 64.77 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.342 0.591 . . . . 0.0 109.995 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 9' ' ' GLY . 0.9 OUTLIER -90.61 -9.28 47.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.76 179.09 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.596 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.259 -176.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.761 0.315 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -165.91 161.85 17.88 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.4 tp -80.29 -66.65 0.85 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.811 0.339 . . . . 0.0 111.625 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.2 mm -57.61 -34.88 48.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.327 -173.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -77.25 -18.86 57.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 110.245 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.1 -36.47 16.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.804 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 20.6 t -59.31 -56.98 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.905 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.442 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 99.8 mtt180 -65.79 -36.48 83.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.877 -176.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.42 -7.42 68.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.839 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.552 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.5 t80 -89.46 -56.86 3.09 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 122.692 0.397 . . . . 0.0 110.652 177.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.629 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 49.3 p-90 -81.19 -36.73 29.75 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.327 -175.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.84 -23.58 66.7 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.013 0.37 . . . . 0.0 110.972 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.98 -14.53 31.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.087 0.47 . . . . 0.0 110.968 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -101.22 -44.79 5.56 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -174.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 32.7 mmtp -62.87 -30.59 71.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.663 0.744 . . . . 0.0 109.986 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.43 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 2.4 p -69.43 118.34 61.35 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.805 175.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 16' ' ' VAL . 27.3 Cg_endo -67.52 118.74 5.82 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.343 2.029 . . . . 0.0 110.85 174.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.2 pt -114.76 37.4 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.427 0.632 . . . . 0.0 110.856 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -83.95 -24.06 30.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.094 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -61.39 137.82 94.65 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.334 174.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.18 78.79 2.53 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.684 2.256 . . . . 0.0 112.654 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.371 -0.823 . . . . 0.0 109.925 176.25 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 27.1 tp . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 121.285 0.564 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -139.79 172.11 13.25 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.8 tp -77.88 -67.14 0.76 Allowed 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.317 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.0 mm -59.49 -34.34 54.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.325 -173.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -77.05 -20.38 55.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.146 0.498 . . . . 0.0 110.125 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.77 -35.67 20.59 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.563 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 45.8 t -64.23 -58.39 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.322 177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -69.53 -32.56 71.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.392 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.08 -1.87 70.12 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.722 172.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.563 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 5.2 t80 -92.84 -63.15 1.26 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 122.383 0.273 . . . . 0.0 110.618 171.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.543 ' O ' ' HG3' ' A' ' 15' ' ' LYS . 65.3 p-90 -80.35 -25.59 39.15 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -169.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.2 mt -75.5 -18.01 59.95 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 m -91.56 -17.79 25.09 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 113.334 -1.757 . . . . 0.0 111.482 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -100.67 -56.55 2.31 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 11' ' ' TRP . 67.6 mttt -56.59 -32.96 65.75 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.28 0.562 . . . . 0.0 111.465 -172.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.459 HG22 HG23 ' A' ' 18' ' ' ILE . 2.0 p -60.62 112.97 6.43 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.424 174.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.46 118.41 5.67 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.687 2.258 . . . . 0.0 112.26 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.459 HG23 HG22 ' A' ' 16' ' ' VAL . 26.4 pt -131.83 40.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.364 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -94.01 -21.09 19.39 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.463 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -92.31 154.44 42.92 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -79.75 27.01 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.562 2.175 . . . . 0.0 112.365 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.3 p . . . . . 0 C--O 1.251 1.159 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.909 179.594 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 50.6 tp . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 120.864 0.364 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -83.82 -172.98 4.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.955 0.407 . . . . 0.0 111.381 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.0 tp -82.09 -56.04 4.19 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.225 173.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.3 mm -70.93 -31.32 45.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.094 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -78.54 -18.5 54.6 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.511 0.672 . . . . 0.0 109.679 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.95 -35.15 20.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.618 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.562 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 14.1 t -60.84 -56.56 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.135 175.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.482 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 82.6 mtp180 -64.4 -38.74 92.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.635 -176.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.31 -1.6 57.52 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.943 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.562 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.9 t80 -93.9 -58.62 2.2 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 122.539 0.335 . . . . 0.0 111.43 172.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.482 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 63.4 p-90 -80.22 -25.86 39.39 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -170.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.26 -25.02 63.16 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 122.049 0.928 . . . . 0.0 109.105 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.38 -24.58 36.9 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.776 -1.556 . . . . 0.0 111.921 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -103.34 -36.32 8.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.461 ' C ' ' HD2' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -60.74 -25.96 66.86 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.316 0.579 . . . . 0.0 110.784 -176.407 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.411 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 2.3 p -64.69 112.93 9.02 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.568 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.58 117.07 4.59 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.926 1.751 . . . . 0.0 111.383 177.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.2 pt -93.19 38.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.759 0.79 . . . . 0.0 110.636 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -87.07 -13.78 43.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.469 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -90.89 153.11 45.1 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.61 47.55 1.92 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.763 2.309 . . . . 0.0 111.414 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.246 0.884 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.869 -178.194 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 57.6 tp . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -78.18 164.03 25.3 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.1 tp -86.44 -66.07 0.94 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.976 0.417 . . . . 0.0 111.575 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.6 mm -56.59 -33.22 39.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -172.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -74.87 -23.73 58.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.148 0.499 . . . . 0.0 110.24 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.02 -34.12 19.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.829 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 21.6 t -60.43 -57.17 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.163 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -66.31 -34.34 77.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.506 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.86 -3.93 69.75 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.725 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.554 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.5 t80 -92.43 -59.81 1.99 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 122.542 0.337 . . . . 0.0 110.976 174.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.525 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 59.8 p-90 -81.19 -27.08 35.51 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -171.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.7 mt -77.37 -24.14 50.66 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.9 m -89.7 -5.43 57.05 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.387 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.03 -45.49 5.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.058 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 33.8 mmtp -57.11 -26.02 59.77 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.946 0.879 . . . . 0.0 109.886 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 p -92.33 116.01 65.74 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.349 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -67.05 117.65 4.96 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.063 1.842 . . . . 0.0 111.204 174.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.5 pt -87.69 31.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.609 0.718 . . . . 0.0 111.524 -175.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -102.46 -10.34 19.47 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.532 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -76.83 138.3 66.05 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.18 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.61 69.76 5.14 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.782 2.321 . . . . 0.0 111.917 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.7 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.538 -178.587 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.717 0.294 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 60.57 -171.92 0.14 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.276 0.56 . . . . 0.0 111.866 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 7' ' ' VAL . 39.8 tp -90.33 -57.09 2.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.366 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.9 mm -70.85 -30.54 42.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.423 -169.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -79.78 -18.7 50.37 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.49 0.662 . . . . 0.0 109.39 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.81 -23.89 25.2 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.326 176.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.601 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 41.3 t -82.48 -58.02 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.868 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -69.19 -37.54 78.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.792 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.44 -3.8 54.91 Favored Glycine 0 C--O 1.227 -0.313 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.593 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.601 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 5.5 t80 -91.13 -63.49 1.26 Allowed 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 174.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -81.06 -25.16 37.3 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -170.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt -76.22 -22.76 54.83 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.6 m -90.12 -11.38 41.4 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 113.355 -1.748 . . . . 0.0 110.553 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -102.34 -49.89 3.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.397 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.513 ' C ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -66.28 -23.38 66.38 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.168 0.508 . . . . 0.0 110.968 -175.303 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.435 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 4.4 p -62.1 116.87 24.62 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.905 175.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.92 116.68 4.69 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.933 1.755 . . . . 0.0 110.903 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.3 pt -89.76 35.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.812 0.815 . . . . 0.0 110.599 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -105.69 -13.63 15.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.774 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -85.71 148.56 49.08 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.09 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.66 55.6 5.57 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.546 2.164 . . . . 0.0 111.623 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.91 -0.567 . . . . 0.0 109.606 -178.446 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.409 ' C ' ' HD2' ' A' ' 2' ' ' ARG . 93.8 mt . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 120.481 0.181 . . . . 0.0 111.312 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.409 ' HD2' ' C ' ' A' ' 1' ' ' LEU . 5.9 mpt_? -121.87 130.14 53.14 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.309 0.576 . . . . 0.0 110.73 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.4 tp -90.05 -54.97 3.8 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.457 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.4 mm -67.45 -31.45 52.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.256 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -79.54 -18.42 51.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.183 0.516 . . . . 0.0 109.788 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.01 -34.0 22.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.56 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 37.2 t -67.31 -60.5 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.919 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.473 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 61.7 mtp180 -65.74 -36.43 83.55 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.352 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.48 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . -74.48 -2.1 62.77 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.894 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.56 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.2 t80 -90.0 -61.18 1.74 Allowed 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 175.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.473 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 40.6 p-90 -77.2 -35.54 55.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.015 -174.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.3 -38.22 89.55 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.2 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -81.28 -13.29 58.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.559 -177.111 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -101.86 -42.24 6.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -60.63 -21.92 63.24 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.412 0.625 . . . . 0.0 110.748 -177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 16' ' ' VAL . 2.6 p -73.7 117.56 61.94 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.453 174.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.51 118.35 5.59 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.098 1.866 . . . . 0.0 111.026 174.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.0 pt -81.39 40.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.657 0.741 . . . . 0.0 110.999 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -99.44 -8.7 24.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.532 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -75.47 146.1 80.33 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.56 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.65 49.26 2.1 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.776 2.317 . . . . 0.0 112.333 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.248 1.016 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.61 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.518 ' NE ' ' HA ' ' A' ' 2' ' ' ARG . 1.0 OUTLIER -122.47 176.82 5.7 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.486 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.408 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 42.9 tp -85.28 -67.84 0.77 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.007 0.432 . . . . 0.0 111.281 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.5 mm -61.33 -30.66 48.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.865 -174.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -78.6 -18.48 54.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.283 0.563 . . . . 0.0 110.076 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.88 -39.8 17.83 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 25.4 t -59.6 -56.96 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.048 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 99.8 mtt180 -69.17 -28.51 66.48 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.84 -9.27 87.02 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.309 173.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.517 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.2 t80 -84.82 -61.78 1.7 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.061 173.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.49 ' O ' ' HG3' ' A' ' 15' ' ' LYS . 44.1 p-90 -80.44 -39.3 28.44 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -171.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 83.5 mt -66.06 -29.14 69.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.622 0.725 . . . . 0.0 110.405 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.67 -17.08 39.68 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.459 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -103.46 -40.52 6.32 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -65.65 -24.18 66.96 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.096 0.474 . . . . 0.0 110.939 -176.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.481 HG22 HG23 ' A' ' 18' ' ' ILE . 3.1 p -58.89 115.7 12.84 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.726 175.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 16' ' ' VAL . 36.3 Cg_endo -68.9 116.78 4.63 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.978 1.786 . . . . 0.0 111.178 175.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.481 HG23 HG22 ' A' ' 16' ' ' VAL . 3.3 pt -142.99 41.52 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.584 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -97.95 -15.39 20.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.056 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.696 ' HD2' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -56.84 143.53 69.92 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.222 177.409 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -88.6 37.35 0.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.951 2.434 . . . . 0.0 112.801 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.446 ' OG ' ' HD3' ' A' ' 20' ' ' ARG . 15.6 m . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.56 -0.733 . . . . 0.0 110.504 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 121.144 0.497 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.472 ' HG3' ' H ' ' A' ' 3' ' ' LEU . 17.3 tpt180 -167.11 176.16 7.03 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.472 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 37.2 tp -83.96 -69.02 0.67 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.515 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.8 mm -59.9 -33.35 52.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.056 -174.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -74.3 -18.38 60.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.451 0.644 . . . . 0.0 110.008 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.02 -36.54 14.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.058 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.524 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 21.8 t -58.95 -56.64 15.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.214 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -66.73 -33.14 74.97 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.489 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.54 -2.24 74.19 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.74 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.524 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.8 t80 -92.69 -62.6 1.36 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 122.28 0.232 . . . . 0.0 110.729 173.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -80.14 -23.21 41.29 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -169.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.3 -36.61 53.97 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.3 m -72.51 -11.65 60.75 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.219 -1.81 . . . . 0.0 111.278 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -101.68 -49.21 4.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.979 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -63.59 -22.1 66.71 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.998 0.428 . . . . 0.0 111.472 -176.762 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.563 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 3.7 p -58.49 115.33 11.2 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.055 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.98 119.45 6.44 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.196 1.931 . . . . 0.0 111.019 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.5 pt -87.93 39.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.863 0.839 . . . . 0.0 110.214 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -92.26 -26.4 18.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.231 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -63.64 133.65 95.6 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.637 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -82.8 27.93 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.734 2.29 . . . . 0.0 112.598 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.31 -0.853 . . . . 0.0 109.953 -179.649 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 54.5 tp . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.533 0.206 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' A' ' 2' ' ' ARG . 0.8 OUTLIER -167.79 172.43 9.16 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.804 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.434 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 43.5 tp -74.29 -70.1 0.41 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -177.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.7 mm -56.24 -35.15 41.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.116 0.484 . . . . 0.0 112.156 -174.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -71.28 -22.36 61.97 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.187 0.518 . . . . 0.0 110.116 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.8 -36.19 15.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.473 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.572 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 18.8 t -57.36 -55.73 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.532 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -65.55 -37.8 87.74 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.98 -175.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.19 -2.63 63.0 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.703 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.572 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.2 t80 -91.44 -62.62 1.4 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 122.273 0.229 . . . . 0.0 110.418 174.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 58.9 p-90 -79.0 -26.0 43.3 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -170.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.4 mt -75.85 -33.95 60.04 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 97.8 m -84.27 -4.9 59.14 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 113.483 -1.69 . . . . 0.0 110.893 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -102.2 -38.64 7.6 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.106 -0.371 . . . . 0.0 111.525 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.49 ' HD2' ' N ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -68.52 -23.29 64.52 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.328 -177.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.49 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 2.9 p -52.89 114.18 5.51 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.175 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -67.32 116.39 4.18 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.145 1.897 . . . . 0.0 111.863 176.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.2 pt -141.82 38.14 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.354 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -99.28 -22.34 15.64 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.718 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 26.9 mmm180 -83.08 168.19 24.41 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 20' ' ' ARG . 64.5 Cg_endo -82.5 35.38 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.174 1.916 . . . . 0.0 112.617 -174.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.315 -0.85 . . . . 0.0 111.502 176.703 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 65.7 tp . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 110.838 -0.06 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 1' ' ' LEU . 5.3 mpt_? 71.27 129.81 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 122.038 0.923 . . . . 0.0 111.397 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.2 tp -80.55 -57.79 3.42 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.157 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.9 mm -63.85 -32.27 56.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.625 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -75.41 -27.16 58.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.196 0.522 . . . . 0.0 109.971 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.76 -26.3 32.0 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.137 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.577 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 24.8 t -72.27 -58.44 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.798 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -65.65 -38.37 89.17 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.685 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.61 -3.22 58.11 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.035 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.577 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.8 t80 -91.11 -63.81 1.21 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.645 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 58.7 p-90 -80.96 -26.37 36.66 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -169.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.2 mt -76.55 -25.53 54.16 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.115 0.959 . . . . 0.0 108.623 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.3 m -84.64 -11.34 56.14 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.793 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -103.12 -38.88 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 44.7 mmtm -56.54 -40.35 74.94 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.376 0.608 . . . . 0.0 110.605 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.445 ' H ' HG12 ' A' ' 16' ' ' VAL . 1.4 p -56.63 111.73 3.64 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.94 171.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 16' ' ' VAL . 54.0 Cg_endo -70.91 117.12 4.98 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.058 1.839 . . . . 0.0 111.31 177.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.8 pt -93.02 25.43 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.861 0.838 . . . . 0.0 110.387 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -108.54 -13.26 14.87 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.478 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -93.16 149.67 37.86 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.824 177.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.6 60.61 5.15 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.781 2.321 . . . . 0.0 112.907 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.249 1.052 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 177.131 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 121.302 0.572 . . . . 0.0 111.337 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.461 ' HG3' ' H ' ' A' ' 3' ' ' LEU . 15.3 tpp180 -127.09 176.35 7.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.461 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 36.9 tp -88.24 -70.46 0.64 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.693 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.0 mm -59.54 -33.92 53.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -173.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -75.59 -18.31 59.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.241 0.543 . . . . 0.0 110.006 -177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.12 -39.47 13.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.903 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 22.0 t -57.25 -57.63 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.475 177.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.528 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 81.5 mtp180 -63.8 -42.02 97.79 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.018 -174.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.63 -13.51 63.45 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.964 176.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.552 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.9 t80 -82.47 -59.77 2.42 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 122.365 0.266 . . . . 0.0 110.644 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.54 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 59.1 p-90 -75.91 -33.83 59.91 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.234 -174.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.34 -31.78 73.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.951 0.405 . . . . 0.0 110.619 177.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -91.2 -4.65 55.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.518 0.675 . . . . 0.0 110.685 -179.054 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 11' ' ' TRP . 0.3 OUTLIER -100.31 -51.65 3.59 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.237 -175.615 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 33.5 mmtp -59.95 -40.72 89.95 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.244 0.545 . . . . 0.0 110.384 -176.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 p -55.61 116.17 11.29 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.008 175.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.52 118.04 5.04 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.133 1.889 . . . . 0.0 111.283 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.7 pt -131.53 37.54 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.536 0.684 . . . . 0.0 110.928 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -99.92 -71.43 0.7 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.725 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -103.59 133.09 20.47 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.895 173.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.53 50.36 3.37 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.602 2.201 . . . . 0.0 111.739 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.248 1.025 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.191 -177.311 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.587 ' O ' ' HB2' ' A' ' 5' ' ' HIS . 5.9 mp . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 110.581 -0.155 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.519 ' HG3' ' H ' ' A' ' 3' ' ' LEU . 7.9 tpp180 59.94 -169.34 0.15 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.588 0.355 . . . . 0.0 110.449 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.519 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 43.7 tp -90.65 -67.89 0.82 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.001 0.429 . . . . 0.0 110.947 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.0 mm -61.67 -31.43 50.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.319 -176.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.587 ' HB2' ' O ' ' A' ' 1' ' ' LEU . 35.1 m-70 -76.57 -19.68 57.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.216 0.531 . . . . 0.0 110.042 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.66 -35.86 19.09 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.586 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 36.5 t -63.19 -57.05 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.842 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -69.95 -32.2 70.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.447 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.14 -4.06 62.42 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.522 173.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.586 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.6 t80 -91.89 -63.88 1.19 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 122.562 0.345 . . . . 0.0 110.289 173.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -80.7 -27.7 36.92 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -171.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.8 mt -76.66 -37.04 56.9 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 m -74.76 -9.38 58.5 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.73 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -100.58 -51.66 3.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.909 177.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -60.53 -25.13 65.9 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.946 0.403 . . . . 0.0 111.191 -176.552 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.404 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 4.2 p -63.24 115.34 17.13 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.958 175.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.05 116.97 4.92 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.889 1.726 . . . . 0.0 111.166 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.9 pt -95.03 35.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.812 0.815 . . . . 0.0 110.295 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -110.19 -17.3 13.57 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.077 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -97.47 114.63 65.14 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.605 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -83.93 47.6 2.32 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.673 2.249 . . . . 0.0 112.007 177.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.5 m . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.638 -176.92 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -152.6 169.12 23.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.6 tp -83.27 -70.19 0.58 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.056 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.7 mm -59.69 -32.81 50.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.108 -173.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -77.42 -19.44 56.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.165 0.507 . . . . 0.0 110.15 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.52 -36.39 20.54 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 30.4 t -61.77 -60.92 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.42 -1.264 . . . . 0.0 111.172 175.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.48 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 77.8 mtp180 -63.82 -39.07 93.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.704 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.54 -11.19 68.14 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.148 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.557 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.5 t80 -81.8 -58.78 2.84 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.519 0.328 . . . . 0.0 110.48 178.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.652 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 36.5 p-90 -80.18 -36.58 34.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.079 -0.649 . . . . 0.0 112.294 -174.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.81 -29.8 70.99 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.227 -0.296 . . . . 0.0 111.366 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.0 -10.28 53.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.368 0.604 . . . . 0.0 110.685 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -102.55 -42.86 5.8 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 74.1 mmtt -59.71 -37.51 79.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.184 0.516 . . . . 0.0 110.36 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.6 p -56.31 113.2 5.43 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.438 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.33 118.73 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.522 2.148 . . . . 0.0 111.669 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.2 pt -89.22 44.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.61 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -104.59 0.61 28.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.874 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.428 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 34.4 mmt180 -90.8 169.45 11.77 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.334 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 20' ' ' ARG . 72.7 Cg_endo -86.97 37.15 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.512 2.141 . . . . 0.0 111.845 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.0 p . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.665 -178.859 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -85.84 119.73 26.47 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.2 tp -46.75 -60.82 2.16 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 124.191 0.932 . . . . 0.0 112.901 -170.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.4 mm -58.82 -31.28 44.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.131 -174.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -80.22 -19.06 47.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.428 0.632 . . . . 0.0 109.865 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.54 -35.56 15.85 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.028 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.55 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 13.8 t -56.18 -56.36 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.113 172.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.441 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 97.7 mtt180 -64.4 -39.04 93.09 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.921 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.47 -3.01 65.06 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.032 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.55 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.7 t80 -89.26 -58.93 2.36 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.623 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 39.3 p-90 -80.02 -37.74 33.47 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.199 -174.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.3 mt -63.33 -27.6 69.43 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.981 0.419 . . . . 0.0 110.669 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.74 -10.3 43.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.107 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -102.2 -42.18 6.13 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 74.7 mmtt -54.81 -39.47 68.53 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.761 0.791 . . . . 0.0 109.777 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.447 ' H ' HG12 ' A' ' 16' ' ' VAL . 2.3 p -67.54 116.73 40.37 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.627 172.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -67.52 117.57 4.95 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.719 1.613 . . . . 0.0 110.392 173.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.3 pt -84.23 36.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.755 0.788 . . . . 0.0 111.564 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -110.49 -10.73 14.54 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.505 173.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -98.5 145.59 30.13 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.882 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.71 52.95 2.63 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.39 2.06 . . . . 0.0 111.419 171.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.559 178.39 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.93 0.395 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -107.01 161.51 14.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.783 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.6 tp -63.58 -63.85 1.06 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -173.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.0 mm -62.69 -31.59 52.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.225 0.536 . . . . 0.0 111.578 -173.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -77.05 -21.07 55.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.943 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.62 -38.43 17.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 16.9 t -56.4 -58.49 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.121 176.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.507 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 82.2 mtp180 -62.22 -44.54 96.34 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.88 -175.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.22 -5.19 47.33 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.399 176.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.569 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.6 t80 -89.68 -57.72 2.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.41 0.284 . . . . 0.0 110.7 177.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.653 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 52.8 p-90 -78.97 -34.63 44.09 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.916 -174.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.77 -33.35 74.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.882 0.372 . . . . 0.0 111.101 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.08 -6.43 57.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.469 0.652 . . . . 0.0 110.528 -177.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.19 -45.64 5.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.456 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 70.9 mmtt -65.75 -34.6 78.55 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.248 0.547 . . . . 0.0 110.414 -176.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -56.55 115.03 8.93 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.969 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.9 118.48 5.64 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.285 1.99 . . . . 0.0 111.216 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.6 pt -111.43 35.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.59 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -83.76 -53.77 5.38 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.05 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 76.7 mtp180 -71.88 117.19 55.64 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.416 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 20' ' ' ARG . 3.3 Cg_exo -77.05 43.48 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.614 2.209 . . . . 0.0 111.825 175.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.468 -0.777 . . . . 0.0 110.756 179.5 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 121.022 0.439 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.462 ' HG3' ' H ' ' A' ' 3' ' ' LEU . 22.8 tpt180 -152.74 173.95 14.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.462 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 42.2 tp -76.33 -65.62 0.9 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.974 0.416 . . . . 0.0 111.114 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.6 mm -59.23 -32.98 49.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.509 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -74.31 -21.28 59.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.151 0.5 . . . . 0.0 110.125 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.75 -36.63 18.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.926 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.508 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 15.8 t -58.92 -56.06 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.025 175.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.404 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 84.2 mtp180 -66.17 -34.35 77.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.481 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.21 -1.69 64.72 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.668 174.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.508 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.8 t80 -93.7 -60.9 1.65 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 122.448 0.299 . . . . 0.0 111.273 170.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.404 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 63.3 p-90 -80.26 -23.66 40.63 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -168.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.7 mt -72.79 -25.61 61.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.819 0.819 . . . . 0.0 108.847 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.98 -13.72 58.61 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.415 177.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -101.77 -48.04 4.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.17 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -62.8 -25.11 68.07 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.964 0.411 . . . . 0.0 111.176 -177.457 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.421 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 3.4 p -60.37 117.55 25.45 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.194 177.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 16' ' ' VAL . 30.3 Cg_endo -67.22 117.02 4.5 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.313 2.009 . . . . 0.0 111.268 175.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.4 pt -124.73 28.02 2.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.562 0.696 . . . . 0.0 110.761 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -109.26 -62.56 1.47 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.729 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -101.82 128.3 29.12 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.657 171.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -83.14 32.81 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.792 2.328 . . . . 0.0 112.673 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.251 1.183 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.473 178.874 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 121.098 0.475 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.511 ' HA ' ' HE ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -141.34 151.23 43.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.1 tp -57.41 -64.13 0.99 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.3 mm -59.31 -32.08 47.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -76.36 -24.19 54.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.215 0.531 . . . . 0.0 110.056 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.61 -31.9 24.01 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.068 177.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.544 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 18.6 t -63.28 -57.75 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.979 175.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -64.26 -39.78 94.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.118 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.416 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . -74.4 -1.9 61.97 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.111 176.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.544 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.8 t80 -90.16 -64.66 1.1 Allowed 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 174.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -80.85 -30.94 35.61 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -171.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.0 mt -74.38 -23.2 58.96 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.879 0.847 . . . . 0.0 109.349 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 9' ' ' GLY . 1.2 m -86.92 -16.7 35.14 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.396 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -100.38 -58.36 1.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' NZ ' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -65.35 -21.38 66.69 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -172.503 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.41 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 2.5 p -46.14 112.29 1.72 Allowed Pre-proline 0 C--N 1.322 -0.608 0 O-C-N 124.19 0.931 . . . . 0.0 112.003 177.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 16' ' ' VAL . 26.5 Cg_endo -65.2 119.41 6.43 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.382 2.055 . . . . 0.0 111.637 175.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.9 pt -92.08 46.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.318 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -101.71 0.77 36.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.58 0.705 . . . . 0.0 110.012 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.444 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 1.7 mmp_? -61.43 163.75 10.67 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.491 175.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -72.31 43.25 0.6 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.686 2.257 . . . . 0.0 112.181 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.248 1.026 0 C-N-CA 123.501 0.721 . . . . 0.0 110.342 177.649 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.788 0.327 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -102.57 144.66 30.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.477 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.0 tp -89.78 -59.95 2.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.748 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.8 mm -65.73 -32.55 58.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.573 -174.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -76.15 -22.0 55.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.183 0.516 . . . . 0.0 109.687 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.01 -35.62 25.67 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.568 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 12.1 t -58.36 -55.17 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.606 173.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -67.09 -37.96 84.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.771 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.11 -2.41 52.96 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.812 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.568 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.3 t80 -91.85 -62.4 1.43 Allowed 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 122.354 0.262 . . . . 0.0 110.507 173.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.589 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 56.9 p-90 -80.64 -27.71 37.12 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -171.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -76.26 -20.9 56.94 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.023 0.916 . . . . 0.0 108.81 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -91.02 -10.91 40.51 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 113.5 -1.682 . . . . 0.0 110.884 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -101.79 -50.61 3.64 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 30.9 mmtp -57.79 -40.67 80.41 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.489 0.662 . . . . 0.0 110.483 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.416 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 2.4 p -58.28 119.19 33.34 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.361 175.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 16' ' ' VAL . 11.2 Cg_endo -63.26 118.92 5.82 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.998 1.799 . . . . 0.0 110.589 171.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.4 pt -124.38 45.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.778 -176.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -79.12 -30.82 43.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.121 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -91.86 152.15 42.77 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.244 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.77 32.21 0.51 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.593 2.195 . . . . 0.0 112.047 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.413 -178.038 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.865 0.364 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.438 ' HG3' ' H ' ' A' ' 3' ' ' LEU . 15.8 tpp180 -152.33 176.12 11.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.438 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 44.0 tp -83.02 -70.01 0.59 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.682 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.409 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 25.2 mm -58.75 -34.62 52.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.313 -173.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -73.14 -19.15 61.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.405 0.621 . . . . 0.0 109.94 -177.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.5 -37.88 13.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.073 174.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.533 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 14.4 t -57.52 -58.42 6.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.805 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -61.43 -42.17 98.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.566 -173.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.62 -12.13 77.58 Favored Glycine 0 C--O 1.229 -0.196 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.178 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.533 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.1 t80 -80.09 -59.58 2.66 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 122.355 0.262 . . . . 0.0 110.911 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.505 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 46.6 p-90 -80.56 -35.59 34.13 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.016 -173.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.91 -26.57 68.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.668 0.27 . . . . 0.0 111.327 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.06 -15.29 28.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.326 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -100.47 -54.17 2.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -171.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 0.3 OUTLIER -59.58 -33.92 72.06 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.427 0.632 . . . . 0.0 110.207 -174.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.82 111.94 5.78 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.142 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -70.18 117.53 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.866 1.711 . . . . 0.0 111.167 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.3 pt -93.13 53.66 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.668 0.747 . . . . 0.0 110.11 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -110.42 -16.87 13.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.7 -174.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -88.68 130.27 45.76 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.456 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -88.26 30.12 0.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.825 2.35 . . . . 0.0 111.514 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.6 p . . . . . 0 C--O 1.249 1.076 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.838 -178.202 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.3 pp . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 120.665 0.269 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -144.71 127.3 16.08 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.0 tp -50.95 -62.5 1.57 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -168.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.1 mm -59.06 -30.17 43.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.981 -172.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -78.4 -27.52 46.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.27 0.557 . . . . 0.0 109.806 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.34 -31.5 26.76 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.913 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 6.4 t -58.41 -55.05 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.151 172.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.5 mtp85 -63.31 -41.45 98.93 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.444 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.502 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . -71.08 -6.69 61.13 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.779 176.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.596 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 5.0 t80 -89.13 -59.57 2.19 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.76 -0.22 . . . . 0.0 110.468 176.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.551 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 49.1 p-90 -81.58 -34.0 31.28 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -174.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.53 -28.23 64.77 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.342 0.591 . . . . 0.0 109.995 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 9' ' ' GLY . 0.9 OUTLIER -90.61 -9.28 47.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.76 179.09 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.596 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -94.38 -56.14 2.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.259 -176.121 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 70.6 mmtt -63.71 -30.82 71.87 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.036 -172.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 16' ' ' VAL . 2.1 p -63.53 113.81 11.02 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.024 175.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -69.46 116.84 4.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.92 1.746 . . . . 0.0 110.628 174.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 pt -111.48 31.72 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.516 0.674 . . . . 0.0 111.788 -174.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm -101.53 -30.78 11.21 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.097 174.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -75.3 148.02 83.23 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.104 174.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.86 47.95 2.49 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.468 2.112 . . . . 0.0 111.424 171.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 C--O 1.252 1.184 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.834 -176.937 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.4 tp . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.811 0.339 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.2 mm -57.61 -34.88 48.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.327 -173.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -77.25 -18.86 57.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 110.245 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.1 -36.47 16.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.804 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 20.6 t -59.31 -56.98 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.905 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.442 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 99.8 mtt180 -65.79 -36.48 83.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.877 -176.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.42 -7.42 68.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.839 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.552 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.5 t80 -89.46 -56.86 3.09 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 122.692 0.397 . . . . 0.0 110.652 177.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.442 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 49.3 p-90 -81.19 -36.73 29.75 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.327 -175.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.84 -23.58 66.7 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.013 0.37 . . . . 0.0 110.972 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.98 -14.53 31.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.087 0.47 . . . . 0.0 110.968 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -174.262 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.8 tp . . . . . 0 N--CA 1.452 -0.355 0 CA-C-O 121.002 0.43 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.0 mm -59.49 -34.34 54.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.325 -173.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -77.05 -20.38 55.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.146 0.498 . . . . 0.0 110.125 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.77 -35.67 20.59 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.563 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 45.8 t -64.23 -58.39 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.322 177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -69.53 -32.56 71.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.392 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.08 -1.87 70.12 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.722 172.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.563 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 5.2 t80 -92.84 -63.15 1.26 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 122.383 0.273 . . . . 0.0 110.618 171.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -80.35 -25.59 39.15 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -169.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.2 mt -75.5 -18.01 59.95 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 m -91.56 -17.79 25.09 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 113.334 -1.757 . . . . 0.0 111.482 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.0 tp . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 121.106 0.479 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.3 mm -70.93 -31.32 45.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.094 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -78.54 -18.5 54.6 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.511 0.672 . . . . 0.0 109.679 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.95 -35.15 20.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.618 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.562 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 14.1 t -60.84 -56.56 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.135 175.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.482 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 82.6 mtp180 -64.4 -38.74 92.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.635 -176.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.31 -1.6 57.52 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.943 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.562 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.9 t80 -93.9 -58.62 2.2 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 122.539 0.335 . . . . 0.0 111.43 172.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.482 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 63.4 p-90 -80.22 -25.86 39.39 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -170.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.26 -25.02 63.16 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 122.049 0.928 . . . . 0.0 109.105 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.38 -24.58 36.9 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.776 -1.556 . . . . 0.0 111.921 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 . . . . . 0 C--N 1.322 -0.628 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.62 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.1 tp . . . . . 0 N--CA 1.45 -0.436 0 CA-C-O 120.976 0.417 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.6 mm -56.59 -33.22 39.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -172.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -74.87 -23.73 58.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.148 0.499 . . . . 0.0 110.24 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.02 -34.12 19.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.829 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 21.6 t -60.43 -57.17 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.163 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -66.31 -34.34 77.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.506 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.86 -3.93 69.75 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.725 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.554 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.5 t80 -92.43 -59.81 1.99 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 122.542 0.337 . . . . 0.0 110.976 174.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -81.19 -27.08 35.51 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -171.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.7 mt -77.37 -24.14 50.66 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.9 m -89.7 -5.43 57.05 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.387 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.058 -176.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 7' ' ' VAL . 39.8 tp . . . . . 0 N--CA 1.446 -0.638 0 CA-C-O 121.204 0.526 . . . . 0.0 110.366 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.9 mm -70.85 -30.54 42.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.423 -169.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -79.78 -18.7 50.37 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.49 0.662 . . . . 0.0 109.39 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.81 -23.89 25.2 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.326 176.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.601 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 41.3 t -82.48 -58.02 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.868 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -69.19 -37.54 78.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.792 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.44 -3.8 54.91 Favored Glycine 0 C--O 1.227 -0.313 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.593 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.601 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 5.5 t80 -91.13 -63.49 1.26 Allowed 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 174.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -81.06 -25.16 37.3 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -170.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt -76.22 -22.76 54.83 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.6 m -90.12 -11.38 41.4 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 113.355 -1.748 . . . . 0.0 110.553 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.397 179.895 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.4 tp . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.46 0.648 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.4 mm -67.45 -31.45 52.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.256 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -79.54 -18.42 51.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.183 0.516 . . . . 0.0 109.788 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.01 -34.0 22.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.56 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 37.2 t -67.31 -60.5 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.919 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.473 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 61.7 mtp180 -65.74 -36.43 83.55 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.352 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.48 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . -74.48 -2.1 62.77 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.894 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.56 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.2 t80 -90.0 -61.18 1.74 Allowed 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 175.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.473 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 40.6 p-90 -77.2 -35.54 55.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.015 -174.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.3 -38.22 89.55 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.2 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -81.28 -13.29 58.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.559 -177.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.849 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.9 tp . . . . . 0 CA--C 1.52 -0.182 0 CA-C-O 121.007 0.432 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.5 mm -61.33 -30.66 48.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.865 -174.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -78.6 -18.48 54.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.283 0.563 . . . . 0.0 110.076 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.88 -39.8 17.83 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 25.4 t -59.6 -56.96 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.048 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 99.8 mtt180 -69.17 -28.51 66.48 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.84 -9.27 87.02 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.309 173.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.517 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.2 t80 -84.82 -61.78 1.7 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.061 173.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 44.1 p-90 -80.44 -39.3 28.44 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -171.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 83.5 mt -66.06 -29.14 69.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.622 0.725 . . . . 0.0 110.405 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.67 -17.08 39.68 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.459 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 179.247 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.2 tp . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.791 0.329 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.8 mm -59.9 -33.35 52.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.056 -174.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -74.3 -18.38 60.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.451 0.644 . . . . 0.0 110.008 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.02 -36.54 14.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.058 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.524 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 21.8 t -58.95 -56.64 15.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.214 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -66.73 -33.14 74.97 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.489 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.54 -2.24 74.19 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.74 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.524 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.8 t80 -92.69 -62.6 1.36 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 122.28 0.232 . . . . 0.0 110.729 173.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -80.14 -23.21 41.29 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -169.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.3 -36.61 53.97 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.3 m -72.51 -11.65 60.75 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.219 -1.81 . . . . 0.0 111.278 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.979 177.75 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.5 tp . . . . . 0 N--CA 1.457 -0.113 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.7 mm -56.24 -35.15 41.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.116 0.484 . . . . 0.0 112.156 -174.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -71.28 -22.36 61.97 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.187 0.518 . . . . 0.0 110.116 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.8 -36.19 15.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.473 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.572 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 18.8 t -57.36 -55.73 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.532 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -65.55 -37.8 87.74 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.98 -175.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.19 -2.63 63.0 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.703 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.572 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.2 t80 -91.44 -62.62 1.4 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 122.273 0.229 . . . . 0.0 110.418 174.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 58.9 p-90 -79.0 -26.0 43.3 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -170.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.4 mt -75.85 -33.95 60.04 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 97.8 m -84.27 -4.9 59.14 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 113.483 -1.69 . . . . 0.0 110.893 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.326 -0.455 0 O-C-N 122.106 -0.371 . . . . 0.0 111.525 174.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.2 tp . . . . . 0 N--CA 1.448 -0.532 0 CA-C-O 120.955 0.407 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.9 mm -63.85 -32.27 56.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.625 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 -75.41 -27.16 58.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.196 0.522 . . . . 0.0 109.971 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.76 -26.3 32.0 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.137 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.577 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 24.8 t -72.27 -58.44 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.798 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -65.65 -38.37 89.17 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.685 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.61 -3.22 58.11 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.035 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.577 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.8 t80 -91.11 -63.81 1.21 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -80.96 -26.37 36.66 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -169.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.2 mt -76.55 -25.53 54.16 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.115 0.959 . . . . 0.0 108.623 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.3 m -84.64 -11.34 56.14 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.793 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.253 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.9 tp . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.779 0.323 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.0 mm -59.54 -33.92 53.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -173.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -75.59 -18.31 59.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.241 0.543 . . . . 0.0 110.006 -177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.12 -39.47 13.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.903 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 22.0 t -57.25 -57.63 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.475 177.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.528 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 81.5 mtp180 -63.8 -42.02 97.79 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.018 -174.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.63 -13.51 63.45 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.964 176.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.552 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.9 t80 -82.47 -59.77 2.42 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 122.365 0.266 . . . . 0.0 110.644 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.528 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 59.1 p-90 -75.91 -33.83 59.91 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.234 -174.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.34 -31.78 73.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.951 0.405 . . . . 0.0 110.619 177.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -91.2 -4.65 55.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.518 0.675 . . . . 0.0 110.685 -179.054 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 11' ' ' TRP . 0.3 OUTLIER . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.237 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.7 tp . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 121.001 0.429 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.0 mm -61.67 -31.43 50.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.319 -176.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -76.57 -19.68 57.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.216 0.531 . . . . 0.0 110.042 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.66 -35.86 19.09 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.586 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 36.5 t -63.19 -57.05 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.842 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -69.95 -32.2 70.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.447 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.14 -4.06 62.42 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.522 173.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.586 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.6 t80 -91.89 -63.88 1.19 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 122.562 0.345 . . . . 0.0 110.289 173.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -80.7 -27.7 36.92 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -171.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.8 mt -76.66 -37.04 56.9 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 m -74.76 -9.38 58.5 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.73 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.909 177.086 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.6 tp . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.7 mm -59.69 -32.81 50.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.108 -173.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -77.42 -19.44 56.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.165 0.507 . . . . 0.0 110.15 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.52 -36.39 20.54 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 30.4 t -61.77 -60.92 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.42 -1.264 . . . . 0.0 111.172 175.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.48 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 77.8 mtp180 -63.82 -39.07 93.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.704 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.54 -11.19 68.14 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.148 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.557 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.5 t80 -81.8 -58.78 2.84 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.519 0.328 . . . . 0.0 110.48 178.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.48 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 36.5 p-90 -80.18 -36.58 34.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.079 -0.649 . . . . 0.0 112.294 -174.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.81 -29.8 70.99 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.227 -0.296 . . . . 0.0 111.366 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.0 -10.28 53.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.368 0.604 . . . . 0.0 110.685 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 . . . . . 0 C--N 1.319 -0.717 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.504 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.2 tp . . . . . 0 CA--C 1.521 -0.141 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.4 mm -58.82 -31.28 44.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.131 -174.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -80.22 -19.06 47.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.428 0.632 . . . . 0.0 109.865 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.54 -35.56 15.85 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.028 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.55 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 13.8 t -56.18 -56.36 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.113 172.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.441 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 97.7 mtt180 -64.4 -39.04 93.09 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.921 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.47 -3.01 65.06 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.032 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.55 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.7 t80 -89.26 -58.93 2.36 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.441 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 39.3 p-90 -80.02 -37.74 33.47 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.199 -174.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.3 mt -63.33 -27.6 69.43 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.981 0.419 . . . . 0.0 110.669 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.74 -10.3 43.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.107 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.728 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.6 tp . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.0 mm -62.69 -31.59 52.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.225 0.536 . . . . 0.0 111.578 -173.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -77.05 -21.07 55.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.943 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.62 -38.43 17.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 16.9 t -56.4 -58.49 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.121 176.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.507 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 82.2 mtp180 -62.22 -44.54 96.34 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.88 -175.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.22 -5.19 47.33 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.399 176.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.569 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.6 t80 -89.68 -57.72 2.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.41 0.284 . . . . 0.0 110.7 177.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.507 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 52.8 p-90 -78.97 -34.63 44.09 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.916 -174.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.77 -33.35 74.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.882 0.372 . . . . 0.0 111.101 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.08 -6.43 57.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.469 0.652 . . . . 0.0 110.528 -177.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.456 -175.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.2 tp . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 120.974 0.416 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.6 mm -59.23 -32.98 49.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.509 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -74.31 -21.28 59.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.151 0.5 . . . . 0.0 110.125 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.75 -36.63 18.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.926 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.508 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 15.8 t -58.92 -56.06 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.025 175.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.404 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 84.2 mtp180 -66.17 -34.35 77.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.481 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.21 -1.69 64.72 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.668 174.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.508 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.8 t80 -93.7 -60.9 1.65 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 122.448 0.299 . . . . 0.0 111.273 170.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.404 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 63.3 p-90 -80.26 -23.66 40.63 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -168.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.7 mt -72.79 -25.61 61.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.819 0.819 . . . . 0.0 108.847 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.98 -13.72 58.61 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.415 177.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 . . . . . 0 C--N 1.318 -0.778 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.17 -179.549 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.1 tp . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.3 mm -59.31 -32.08 47.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -76.36 -24.19 54.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.215 0.531 . . . . 0.0 110.056 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.61 -31.9 24.01 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.068 177.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.544 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 18.6 t -63.28 -57.75 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.979 175.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -64.26 -39.78 94.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.118 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.416 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . -74.4 -1.9 61.97 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.111 176.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.544 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.8 t80 -90.16 -64.66 1.1 Allowed 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 174.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -80.85 -30.94 35.61 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -171.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.0 mt -74.38 -23.2 58.96 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.879 0.847 . . . . 0.0 109.349 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 9' ' ' GLY . 1.2 m -86.92 -16.7 35.14 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.396 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 . . . . . 0 C--N 1.328 -0.367 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -178.013 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.0 tp . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.145 0.498 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.8 mm -65.73 -32.55 58.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.573 -174.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -76.15 -22.0 55.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.183 0.516 . . . . 0.0 109.687 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.01 -35.62 25.67 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.568 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 12.1 t -58.36 -55.17 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.606 173.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -67.09 -37.96 84.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.771 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.11 -2.41 52.96 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.812 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.568 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.3 t80 -91.85 -62.4 1.43 Allowed 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 122.354 0.262 . . . . 0.0 110.507 173.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 56.9 p-90 -80.64 -27.71 37.12 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -171.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -76.26 -20.9 56.94 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.023 0.916 . . . . 0.0 108.81 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -91.02 -10.91 40.51 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 113.5 -1.682 . . . . 0.0 110.884 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 . . . . . 0 C--N 1.327 -0.386 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -175.132 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.0 tp . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.74 0.305 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.409 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 25.2 mm -58.75 -34.62 52.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.313 -173.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -73.14 -19.15 61.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.405 0.621 . . . . 0.0 109.94 -177.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.5 -37.88 13.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.073 174.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.533 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 14.4 t -57.52 -58.42 6.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.805 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -61.43 -42.17 98.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.566 -173.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.62 -12.13 77.58 Favored Glycine 0 C--O 1.229 -0.196 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.178 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.533 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.1 t80 -80.09 -59.58 2.66 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 122.355 0.262 . . . . 0.0 110.911 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -80.56 -35.59 34.13 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.016 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.91 -26.57 68.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.668 0.27 . . . . 0.0 111.327 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.06 -15.29 28.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.326 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 . . . . . 0 C--N 1.326 -0.417 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -171.905 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.0 tp . . . . . 0 N--CA 1.462 0.16 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.1 mm -59.06 -30.17 43.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.981 -172.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -78.4 -27.52 46.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.27 0.557 . . . . 0.0 109.806 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.34 -31.5 26.76 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.913 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 6.4 t -58.41 -55.05 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.151 172.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.5 mtp85 -63.31 -41.45 98.93 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.444 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.502 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . -71.08 -6.69 61.13 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.779 176.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.596 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 5.0 t80 -89.13 -59.57 2.19 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.76 -0.22 . . . . 0.0 110.468 176.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 49.1 p-90 -81.58 -34.0 31.28 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -174.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.53 -28.23 64.77 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.342 0.591 . . . . 0.0 109.995 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 9' ' ' GLY . 0.9 OUTLIER -90.61 -9.28 47.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.76 179.09 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.596 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.259 -176.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.761 0.315 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -165.91 161.85 17.88 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.4 tp -80.29 -66.65 0.85 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.811 0.339 . . . . 0.0 111.625 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.2 mm -57.61 -34.88 48.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.327 -173.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -77.25 -18.86 57.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 110.245 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.1 -36.47 16.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.804 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 20.6 t -59.31 -56.98 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.905 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.442 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 99.8 mtt180 -65.79 -36.48 83.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.877 -176.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.42 -7.42 68.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.839 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.552 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.5 t80 -89.46 -56.86 3.09 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 122.692 0.397 . . . . 0.0 110.652 177.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.629 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 49.3 p-90 -81.19 -36.73 29.75 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.327 -175.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.84 -23.58 66.7 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.013 0.37 . . . . 0.0 110.972 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.98 -14.53 31.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.087 0.47 . . . . 0.0 110.968 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -101.22 -44.79 5.56 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -174.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 32.7 mmtp -62.87 -30.59 71.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.663 0.744 . . . . 0.0 109.986 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.43 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 2.4 p -69.43 118.34 61.35 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.805 175.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 16' ' ' VAL . 27.3 Cg_endo -67.52 118.74 5.82 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.343 2.029 . . . . 0.0 110.85 174.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.2 pt -114.76 37.4 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.427 0.632 . . . . 0.0 110.856 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -83.95 -24.06 30.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.094 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -61.39 137.82 94.65 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.334 174.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.18 78.79 2.53 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.684 2.256 . . . . 0.0 112.654 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.371 -0.823 . . . . 0.0 109.925 176.25 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 27.1 tp . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 121.285 0.564 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -139.79 172.11 13.25 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.8 tp -77.88 -67.14 0.76 Allowed 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.317 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.0 mm -59.49 -34.34 54.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.325 -173.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -77.05 -20.38 55.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.146 0.498 . . . . 0.0 110.125 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.77 -35.67 20.59 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.563 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 45.8 t -64.23 -58.39 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.322 177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -69.53 -32.56 71.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.392 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.08 -1.87 70.12 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.722 172.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.563 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 5.2 t80 -92.84 -63.15 1.26 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 122.383 0.273 . . . . 0.0 110.618 171.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.543 ' O ' ' HG3' ' A' ' 15' ' ' LYS . 65.3 p-90 -80.35 -25.59 39.15 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -169.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.2 mt -75.5 -18.01 59.95 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 m -91.56 -17.79 25.09 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 113.334 -1.757 . . . . 0.0 111.482 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.67 -56.55 2.31 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 11' ' ' TRP . 67.6 mttt -56.59 -32.96 65.75 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.28 0.562 . . . . 0.0 111.465 -172.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.459 HG22 HG23 ' A' ' 18' ' ' ILE . 2.0 p -60.62 112.97 6.43 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.424 174.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.46 118.41 5.67 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.687 2.258 . . . . 0.0 112.26 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.459 HG23 HG22 ' A' ' 16' ' ' VAL . 26.4 pt -131.83 40.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.364 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -94.01 -21.09 19.39 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.463 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -92.31 154.44 42.92 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -79.75 27.01 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.562 2.175 . . . . 0.0 112.365 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.3 p . . . . . 0 C--O 1.251 1.159 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.909 179.594 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 50.6 tp . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 120.864 0.364 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -83.82 -172.98 4.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.955 0.407 . . . . 0.0 111.381 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.0 tp -82.09 -56.04 4.19 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.225 173.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.3 mm -70.93 -31.32 45.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.094 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -78.54 -18.5 54.6 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.511 0.672 . . . . 0.0 109.679 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.95 -35.15 20.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.618 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.562 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 14.1 t -60.84 -56.56 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.135 175.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.482 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 82.6 mtp180 -64.4 -38.74 92.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.635 -176.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.31 -1.6 57.52 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.943 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.562 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.9 t80 -93.9 -58.62 2.2 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 122.539 0.335 . . . . 0.0 111.43 172.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.482 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 63.4 p-90 -80.22 -25.86 39.39 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -170.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.26 -25.02 63.16 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 122.049 0.928 . . . . 0.0 109.105 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.38 -24.58 36.9 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.776 -1.556 . . . . 0.0 111.921 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -103.34 -36.32 8.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.461 ' C ' ' HD2' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -60.74 -25.96 66.86 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.316 0.579 . . . . 0.0 110.784 -176.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.411 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 2.3 p -64.69 112.93 9.02 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.568 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.58 117.07 4.59 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.926 1.751 . . . . 0.0 111.383 177.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.2 pt -93.19 38.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.759 0.79 . . . . 0.0 110.636 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -87.07 -13.78 43.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.469 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -90.89 153.11 45.1 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.61 47.55 1.92 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.763 2.309 . . . . 0.0 111.414 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.246 0.884 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.869 -178.194 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 57.6 tp . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -78.18 164.03 25.3 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.1 tp -86.44 -66.07 0.94 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.976 0.417 . . . . 0.0 111.575 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.6 mm -56.59 -33.22 39.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -172.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -74.87 -23.73 58.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.148 0.499 . . . . 0.0 110.24 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.02 -34.12 19.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.829 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 21.6 t -60.43 -57.17 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.163 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -66.31 -34.34 77.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.506 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.86 -3.93 69.75 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.725 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.554 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.5 t80 -92.43 -59.81 1.99 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 122.542 0.337 . . . . 0.0 110.976 174.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.525 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 59.8 p-90 -81.19 -27.08 35.51 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -171.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.7 mt -77.37 -24.14 50.66 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.9 m -89.7 -5.43 57.05 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.387 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.03 -45.49 5.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.058 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 33.8 mmtp -57.11 -26.02 59.77 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.946 0.879 . . . . 0.0 109.886 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 p -92.33 116.01 65.74 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.349 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -67.05 117.65 4.96 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.063 1.842 . . . . 0.0 111.204 174.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.5 pt -87.69 31.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.609 0.718 . . . . 0.0 111.524 -175.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -102.46 -10.34 19.47 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.532 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -76.83 138.3 66.05 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.18 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.61 69.76 5.14 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.782 2.321 . . . . 0.0 111.917 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.7 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.538 -178.587 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.717 0.294 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 60.57 -171.92 0.14 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.276 0.56 . . . . 0.0 111.866 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 7' ' ' VAL . 39.8 tp -90.33 -57.09 2.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.366 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.9 mm -70.85 -30.54 42.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.423 -169.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -79.78 -18.7 50.37 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.49 0.662 . . . . 0.0 109.39 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.81 -23.89 25.2 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.326 176.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.601 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 41.3 t -82.48 -58.02 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.868 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -69.19 -37.54 78.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.792 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.44 -3.8 54.91 Favored Glycine 0 C--O 1.227 -0.313 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.593 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.601 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 5.5 t80 -91.13 -63.49 1.26 Allowed 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 174.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -81.06 -25.16 37.3 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -170.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt -76.22 -22.76 54.83 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.6 m -90.12 -11.38 41.4 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 113.355 -1.748 . . . . 0.0 110.553 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -102.34 -49.89 3.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.397 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.513 ' C ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -66.28 -23.38 66.38 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.168 0.508 . . . . 0.0 110.968 -175.303 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.435 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 4.4 p -62.1 116.87 24.62 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.905 175.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.92 116.68 4.69 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.933 1.755 . . . . 0.0 110.903 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.3 pt -89.76 35.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.812 0.815 . . . . 0.0 110.599 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -105.69 -13.63 15.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.774 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -85.71 148.56 49.08 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.09 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.66 55.6 5.57 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.546 2.164 . . . . 0.0 111.623 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.91 -0.567 . . . . 0.0 109.606 -178.446 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.409 ' C ' ' HD2' ' A' ' 2' ' ' ARG . 93.8 mt . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 120.481 0.181 . . . . 0.0 111.312 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.409 ' HD2' ' C ' ' A' ' 1' ' ' LEU . 5.9 mpt_? -121.87 130.14 53.14 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.309 0.576 . . . . 0.0 110.73 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.4 tp -90.05 -54.97 3.8 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.457 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.4 mm -67.45 -31.45 52.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.256 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -79.54 -18.42 51.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.183 0.516 . . . . 0.0 109.788 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.01 -34.0 22.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.56 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 37.2 t -67.31 -60.5 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.919 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.473 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 61.7 mtp180 -65.74 -36.43 83.55 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.352 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.48 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . -74.48 -2.1 62.77 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.894 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.56 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.2 t80 -90.0 -61.18 1.74 Allowed 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 175.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.473 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 40.6 p-90 -77.2 -35.54 55.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.015 -174.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.3 -38.22 89.55 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.2 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -81.28 -13.29 58.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.559 -177.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -101.86 -42.24 6.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -60.63 -21.92 63.24 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.412 0.625 . . . . 0.0 110.748 -177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 16' ' ' VAL . 2.6 p -73.7 117.56 61.94 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.453 174.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.51 118.35 5.59 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.098 1.866 . . . . 0.0 111.026 174.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.0 pt -81.39 40.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.657 0.741 . . . . 0.0 110.999 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -99.44 -8.7 24.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.532 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -75.47 146.1 80.33 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.56 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.65 49.26 2.1 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.776 2.317 . . . . 0.0 112.333 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.248 1.016 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.61 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.518 ' NE ' ' HA ' ' A' ' 2' ' ' ARG . 1.0 OUTLIER -122.47 176.82 5.7 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.408 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 42.9 tp -85.28 -67.84 0.77 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.007 0.432 . . . . 0.0 111.281 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.5 mm -61.33 -30.66 48.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.865 -174.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -78.6 -18.48 54.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.283 0.563 . . . . 0.0 110.076 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.88 -39.8 17.83 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 25.4 t -59.6 -56.96 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.048 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 99.8 mtt180 -69.17 -28.51 66.48 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.84 -9.27 87.02 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.309 173.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.517 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.2 t80 -84.82 -61.78 1.7 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.061 173.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.49 ' O ' ' HG3' ' A' ' 15' ' ' LYS . 44.1 p-90 -80.44 -39.3 28.44 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -171.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 83.5 mt -66.06 -29.14 69.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.622 0.725 . . . . 0.0 110.405 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.67 -17.08 39.68 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.459 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -103.46 -40.52 6.32 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -65.65 -24.18 66.96 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.096 0.474 . . . . 0.0 110.939 -176.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.481 HG22 HG23 ' A' ' 18' ' ' ILE . 3.1 p -58.89 115.7 12.84 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.726 175.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 16' ' ' VAL . 36.3 Cg_endo -68.9 116.78 4.63 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.978 1.786 . . . . 0.0 111.178 175.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.481 HG23 HG22 ' A' ' 16' ' ' VAL . 3.3 pt -142.99 41.52 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.584 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -97.95 -15.39 20.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.056 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.696 ' HD2' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -56.84 143.53 69.92 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.222 177.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -88.6 37.35 0.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.951 2.434 . . . . 0.0 112.801 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.446 ' OG ' ' HD3' ' A' ' 20' ' ' ARG . 15.6 m . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.56 -0.733 . . . . 0.0 110.504 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 121.144 0.497 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.472 ' HG3' ' H ' ' A' ' 3' ' ' LEU . 17.3 tpt180 -167.11 176.16 7.03 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.472 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 37.2 tp -83.96 -69.02 0.67 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.515 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.8 mm -59.9 -33.35 52.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.056 -174.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -74.3 -18.38 60.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.451 0.644 . . . . 0.0 110.008 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.02 -36.54 14.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.058 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.524 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 21.8 t -58.95 -56.64 15.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.214 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -66.73 -33.14 74.97 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.489 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.54 -2.24 74.19 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.74 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.524 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.8 t80 -92.69 -62.6 1.36 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 122.28 0.232 . . . . 0.0 110.729 173.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -80.14 -23.21 41.29 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -169.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.3 -36.61 53.97 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.3 m -72.51 -11.65 60.75 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.219 -1.81 . . . . 0.0 111.278 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -101.68 -49.21 4.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.979 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -63.59 -22.1 66.71 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.998 0.428 . . . . 0.0 111.472 -176.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.563 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 3.7 p -58.49 115.33 11.2 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.055 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.98 119.45 6.44 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.196 1.931 . . . . 0.0 111.019 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.5 pt -87.93 39.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.863 0.839 . . . . 0.0 110.214 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -92.26 -26.4 18.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.231 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -63.64 133.65 95.6 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.637 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -82.8 27.93 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.734 2.29 . . . . 0.0 112.598 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.31 -0.853 . . . . 0.0 109.953 -179.649 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 54.5 tp . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.533 0.206 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' A' ' 2' ' ' ARG . 0.8 OUTLIER -167.79 172.43 9.16 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.434 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 43.5 tp -74.29 -70.1 0.41 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -177.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.7 mm -56.24 -35.15 41.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.116 0.484 . . . . 0.0 112.156 -174.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -71.28 -22.36 61.97 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.187 0.518 . . . . 0.0 110.116 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.8 -36.19 15.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.473 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.572 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 18.8 t -57.36 -55.73 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.532 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -65.55 -37.8 87.74 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.98 -175.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.19 -2.63 63.0 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.703 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.572 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.2 t80 -91.44 -62.62 1.4 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 122.273 0.229 . . . . 0.0 110.418 174.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 58.9 p-90 -79.0 -26.0 43.3 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -170.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.4 mt -75.85 -33.95 60.04 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 97.8 m -84.27 -4.9 59.14 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 113.483 -1.69 . . . . 0.0 110.893 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.2 -38.64 7.6 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.106 -0.371 . . . . 0.0 111.525 174.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.49 ' HD2' ' N ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -68.52 -23.29 64.52 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.328 -177.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.49 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 2.9 p -52.89 114.18 5.51 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.175 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -67.32 116.39 4.18 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.145 1.897 . . . . 0.0 111.863 176.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.2 pt -141.82 38.14 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.354 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -99.28 -22.34 15.64 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.718 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 26.9 mmm180 -83.08 168.19 24.41 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 20' ' ' ARG . 64.5 Cg_endo -82.5 35.38 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.174 1.916 . . . . 0.0 112.617 -174.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.315 -0.85 . . . . 0.0 111.502 176.703 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 65.7 tp . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 110.838 -0.06 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 1' ' ' LEU . 5.3 mpt_? 71.27 129.81 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 122.038 0.923 . . . . 0.0 111.397 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.2 tp -80.55 -57.79 3.42 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.157 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.9 mm -63.85 -32.27 56.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.625 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 -75.41 -27.16 58.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.196 0.522 . . . . 0.0 109.971 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.76 -26.3 32.0 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.137 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.577 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 24.8 t -72.27 -58.44 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.798 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -65.65 -38.37 89.17 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.685 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.61 -3.22 58.11 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.035 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.577 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.8 t80 -91.11 -63.81 1.21 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.645 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 58.7 p-90 -80.96 -26.37 36.66 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -169.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.2 mt -76.55 -25.53 54.16 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.115 0.959 . . . . 0.0 108.623 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.3 m -84.64 -11.34 56.14 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.793 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -103.12 -38.88 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 44.7 mmtm -56.54 -40.35 74.94 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.376 0.608 . . . . 0.0 110.605 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.445 ' H ' HG12 ' A' ' 16' ' ' VAL . 1.4 p -56.63 111.73 3.64 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.94 171.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 16' ' ' VAL . 54.0 Cg_endo -70.91 117.12 4.98 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.058 1.839 . . . . 0.0 111.31 177.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.8 pt -93.02 25.43 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.861 0.838 . . . . 0.0 110.387 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -108.54 -13.26 14.87 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.478 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -93.16 149.67 37.86 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.824 177.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.6 60.61 5.15 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.781 2.321 . . . . 0.0 112.907 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.249 1.052 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 177.131 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 121.302 0.572 . . . . 0.0 111.337 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.461 ' HG3' ' H ' ' A' ' 3' ' ' LEU . 15.3 tpp180 -127.09 176.35 7.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.461 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 36.9 tp -88.24 -70.46 0.64 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.693 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.0 mm -59.54 -33.92 53.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -173.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -75.59 -18.31 59.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.241 0.543 . . . . 0.0 110.006 -177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.12 -39.47 13.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.903 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 22.0 t -57.25 -57.63 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.475 177.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.528 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 81.5 mtp180 -63.8 -42.02 97.79 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.018 -174.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.63 -13.51 63.45 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.964 176.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.552 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.9 t80 -82.47 -59.77 2.42 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 122.365 0.266 . . . . 0.0 110.644 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.54 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 59.1 p-90 -75.91 -33.83 59.91 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.234 -174.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.34 -31.78 73.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.951 0.405 . . . . 0.0 110.619 177.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -91.2 -4.65 55.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.518 0.675 . . . . 0.0 110.685 -179.054 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 11' ' ' TRP . 0.3 OUTLIER -100.31 -51.65 3.59 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.237 -175.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 33.5 mmtp -59.95 -40.72 89.95 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.244 0.545 . . . . 0.0 110.384 -176.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 p -55.61 116.17 11.29 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.008 175.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.52 118.04 5.04 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.133 1.889 . . . . 0.0 111.283 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.7 pt -131.53 37.54 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.536 0.684 . . . . 0.0 110.928 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -99.92 -71.43 0.7 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.725 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -103.59 133.09 20.47 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.895 173.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.53 50.36 3.37 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.602 2.201 . . . . 0.0 111.739 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.248 1.025 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.191 -177.311 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.587 ' O ' ' HB2' ' A' ' 5' ' ' HIS . 5.9 mp . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 110.581 -0.155 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.519 ' HG3' ' H ' ' A' ' 3' ' ' LEU . 7.9 tpp180 59.94 -169.34 0.15 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.588 0.355 . . . . 0.0 110.449 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.519 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 43.7 tp -90.65 -67.89 0.82 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.001 0.429 . . . . 0.0 110.947 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.0 mm -61.67 -31.43 50.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.319 -176.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.587 ' HB2' ' O ' ' A' ' 1' ' ' LEU . 35.1 m-70 -76.57 -19.68 57.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.216 0.531 . . . . 0.0 110.042 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.66 -35.86 19.09 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.586 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 36.5 t -63.19 -57.05 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.842 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -69.95 -32.2 70.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.447 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.14 -4.06 62.42 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.522 173.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.586 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.6 t80 -91.89 -63.88 1.19 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 122.562 0.345 . . . . 0.0 110.289 173.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -80.7 -27.7 36.92 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -171.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.8 mt -76.66 -37.04 56.9 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 m -74.76 -9.38 58.5 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.73 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -100.58 -51.66 3.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.909 177.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -60.53 -25.13 65.9 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.946 0.403 . . . . 0.0 111.191 -176.552 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.404 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 4.2 p -63.24 115.34 17.13 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.958 175.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.05 116.97 4.92 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.889 1.726 . . . . 0.0 111.166 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.9 pt -95.03 35.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.812 0.815 . . . . 0.0 110.295 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -110.19 -17.3 13.57 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.077 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -97.47 114.63 65.14 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.605 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -83.93 47.6 2.32 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.673 2.249 . . . . 0.0 112.007 177.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.5 m . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.638 -176.92 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -152.6 169.12 23.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.6 tp -83.27 -70.19 0.58 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.056 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.7 mm -59.69 -32.81 50.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.108 -173.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -77.42 -19.44 56.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.165 0.507 . . . . 0.0 110.15 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.52 -36.39 20.54 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 30.4 t -61.77 -60.92 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.42 -1.264 . . . . 0.0 111.172 175.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.48 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 77.8 mtp180 -63.82 -39.07 93.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.704 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.54 -11.19 68.14 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.148 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.557 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.5 t80 -81.8 -58.78 2.84 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.519 0.328 . . . . 0.0 110.48 178.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.652 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 36.5 p-90 -80.18 -36.58 34.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.079 -0.649 . . . . 0.0 112.294 -174.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.81 -29.8 70.99 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.227 -0.296 . . . . 0.0 111.366 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.0 -10.28 53.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.368 0.604 . . . . 0.0 110.685 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -102.55 -42.86 5.8 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 74.1 mmtt -59.71 -37.51 79.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.184 0.516 . . . . 0.0 110.36 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.6 p -56.31 113.2 5.43 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.438 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.33 118.73 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.522 2.148 . . . . 0.0 111.669 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.2 pt -89.22 44.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.61 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -104.59 0.61 28.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.874 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.428 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 34.4 mmt180 -90.8 169.45 11.77 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.334 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 20' ' ' ARG . 72.7 Cg_endo -86.97 37.15 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.512 2.141 . . . . 0.0 111.845 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.0 p . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.665 -178.859 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -85.84 119.73 26.47 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.2 tp -46.75 -60.82 2.16 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 124.191 0.932 . . . . 0.0 112.901 -170.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.4 mm -58.82 -31.28 44.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.131 -174.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -80.22 -19.06 47.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.428 0.632 . . . . 0.0 109.865 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.54 -35.56 15.85 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.028 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.55 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 13.8 t -56.18 -56.36 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.113 172.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.441 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 97.7 mtt180 -64.4 -39.04 93.09 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.921 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.47 -3.01 65.06 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.032 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.55 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.7 t80 -89.26 -58.93 2.36 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.623 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 39.3 p-90 -80.02 -37.74 33.47 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.199 -174.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.3 mt -63.33 -27.6 69.43 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.981 0.419 . . . . 0.0 110.669 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.74 -10.3 43.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.107 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -102.2 -42.18 6.13 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 74.7 mmtt -54.81 -39.47 68.53 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.761 0.791 . . . . 0.0 109.777 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.447 ' H ' HG12 ' A' ' 16' ' ' VAL . 2.3 p -67.54 116.73 40.37 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.627 172.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -67.52 117.57 4.95 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.719 1.613 . . . . 0.0 110.392 173.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.3 pt -84.23 36.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.755 0.788 . . . . 0.0 111.564 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -110.49 -10.73 14.54 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.505 173.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -98.5 145.59 30.13 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.882 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.71 52.95 2.63 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.39 2.06 . . . . 0.0 111.419 171.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.559 178.39 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.93 0.395 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -107.01 161.51 14.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.783 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.6 tp -63.58 -63.85 1.06 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -173.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.0 mm -62.69 -31.59 52.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.225 0.536 . . . . 0.0 111.578 -173.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -77.05 -21.07 55.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.943 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.62 -38.43 17.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 16.9 t -56.4 -58.49 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.121 176.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.507 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 82.2 mtp180 -62.22 -44.54 96.34 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.88 -175.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.22 -5.19 47.33 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.399 176.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.569 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.6 t80 -89.68 -57.72 2.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.41 0.284 . . . . 0.0 110.7 177.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.653 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 52.8 p-90 -78.97 -34.63 44.09 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.916 -174.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.77 -33.35 74.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.882 0.372 . . . . 0.0 111.101 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.08 -6.43 57.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.469 0.652 . . . . 0.0 110.528 -177.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.19 -45.64 5.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.456 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 70.9 mmtt -65.75 -34.6 78.55 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.248 0.547 . . . . 0.0 110.414 -176.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -56.55 115.03 8.93 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.969 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.9 118.48 5.64 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.285 1.99 . . . . 0.0 111.216 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.6 pt -111.43 35.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.59 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -83.76 -53.77 5.38 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.05 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 76.7 mtp180 -71.88 117.19 55.64 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.416 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 20' ' ' ARG . 3.3 Cg_exo -77.05 43.48 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.614 2.209 . . . . 0.0 111.825 175.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.468 -0.777 . . . . 0.0 110.756 179.5 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 121.022 0.439 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.462 ' HG3' ' H ' ' A' ' 3' ' ' LEU . 22.8 tpt180 -152.74 173.95 14.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.462 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 42.2 tp -76.33 -65.62 0.9 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.974 0.416 . . . . 0.0 111.114 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.6 mm -59.23 -32.98 49.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.509 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -74.31 -21.28 59.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.151 0.5 . . . . 0.0 110.125 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.75 -36.63 18.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.926 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.508 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 15.8 t -58.92 -56.06 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.025 175.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.404 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 84.2 mtp180 -66.17 -34.35 77.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.481 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.21 -1.69 64.72 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.668 174.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.508 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.8 t80 -93.7 -60.9 1.65 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 122.448 0.299 . . . . 0.0 111.273 170.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.404 ' NE1' ' HA ' ' A' ' 8' ' ' ARG . 63.3 p-90 -80.26 -23.66 40.63 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -168.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.7 mt -72.79 -25.61 61.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.819 0.819 . . . . 0.0 108.847 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.98 -13.72 58.61 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.415 177.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -101.77 -48.04 4.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.17 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -62.8 -25.11 68.07 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.964 0.411 . . . . 0.0 111.176 -177.457 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.421 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 3.4 p -60.37 117.55 25.45 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.194 177.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 16' ' ' VAL . 30.3 Cg_endo -67.22 117.02 4.5 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.313 2.009 . . . . 0.0 111.268 175.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.4 pt -124.73 28.02 2.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.562 0.696 . . . . 0.0 110.761 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -109.26 -62.56 1.47 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.729 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -101.82 128.3 29.12 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.657 171.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -83.14 32.81 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.792 2.328 . . . . 0.0 112.673 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.251 1.183 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.473 178.874 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 121.098 0.475 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.511 ' HA ' ' HE ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -141.34 151.23 43.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.1 tp -57.41 -64.13 0.99 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.3 mm -59.31 -32.08 47.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -76.36 -24.19 54.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.215 0.531 . . . . 0.0 110.056 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.61 -31.9 24.01 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.068 177.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.544 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 18.6 t -63.28 -57.75 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.979 175.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -64.26 -39.78 94.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.118 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.416 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . -74.4 -1.9 61.97 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.111 176.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.544 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 2.8 t80 -90.16 -64.66 1.1 Allowed 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 174.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -80.85 -30.94 35.61 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -171.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.0 mt -74.38 -23.2 58.96 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.879 0.847 . . . . 0.0 109.349 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 9' ' ' GLY . 1.2 m -86.92 -16.7 35.14 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.396 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -100.38 -58.36 1.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' NZ ' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -65.35 -21.38 66.69 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -172.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.41 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 2.5 p -46.14 112.29 1.72 Allowed Pre-proline 0 C--N 1.322 -0.608 0 O-C-N 124.19 0.931 . . . . 0.0 112.003 177.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 16' ' ' VAL . 26.5 Cg_endo -65.2 119.41 6.43 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.382 2.055 . . . . 0.0 111.637 175.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.9 pt -92.08 46.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.318 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -101.71 0.77 36.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.58 0.705 . . . . 0.0 110.012 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.444 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 1.7 mmp_? -61.43 163.75 10.67 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.491 175.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -72.31 43.25 0.6 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.686 2.257 . . . . 0.0 112.181 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.248 1.026 0 C-N-CA 123.501 0.721 . . . . 0.0 110.342 177.649 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.788 0.327 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -102.57 144.66 30.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.477 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.0 tp -89.78 -59.95 2.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.748 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.8 mm -65.73 -32.55 58.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.573 -174.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -76.15 -22.0 55.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.183 0.516 . . . . 0.0 109.687 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.01 -35.62 25.67 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.568 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 12.1 t -58.36 -55.17 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.606 173.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -67.09 -37.96 84.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.771 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.11 -2.41 52.96 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.812 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.568 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.3 t80 -91.85 -62.4 1.43 Allowed 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 122.354 0.262 . . . . 0.0 110.507 173.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.589 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 56.9 p-90 -80.64 -27.71 37.12 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -171.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -76.26 -20.9 56.94 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.023 0.916 . . . . 0.0 108.81 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -91.02 -10.91 40.51 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 113.5 -1.682 . . . . 0.0 110.884 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -101.79 -50.61 3.64 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 30.9 mmtp -57.79 -40.67 80.41 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.489 0.662 . . . . 0.0 110.483 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.416 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 2.4 p -58.28 119.19 33.34 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.361 175.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 16' ' ' VAL . 11.2 Cg_endo -63.26 118.92 5.82 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.998 1.799 . . . . 0.0 110.589 171.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.4 pt -124.38 45.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.778 -176.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -79.12 -30.82 43.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.121 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -91.86 152.15 42.77 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.244 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.77 32.21 0.51 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.593 2.195 . . . . 0.0 112.047 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.413 -178.038 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.865 0.364 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.438 ' HG3' ' H ' ' A' ' 3' ' ' LEU . 15.8 tpp180 -152.33 176.12 11.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.438 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 44.0 tp -83.02 -70.01 0.59 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.682 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.409 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 25.2 mm -58.75 -34.62 52.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.313 -173.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -73.14 -19.15 61.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.405 0.621 . . . . 0.0 109.94 -177.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.5 -37.88 13.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.073 174.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.533 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 14.4 t -57.52 -58.42 6.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.805 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -61.43 -42.17 98.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.566 -173.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.62 -12.13 77.58 Favored Glycine 0 C--O 1.229 -0.196 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.178 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.533 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 3.1 t80 -80.09 -59.58 2.66 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 122.355 0.262 . . . . 0.0 110.911 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.505 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 46.6 p-90 -80.56 -35.59 34.13 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.016 -173.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.91 -26.57 68.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.668 0.27 . . . . 0.0 111.327 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.06 -15.29 28.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.326 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -100.47 -54.17 2.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -171.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 0.3 OUTLIER -59.58 -33.92 72.06 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.427 0.632 . . . . 0.0 110.207 -174.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.82 111.94 5.78 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.142 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -70.18 117.53 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.866 1.711 . . . . 0.0 111.167 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.3 pt -93.13 53.66 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.668 0.747 . . . . 0.0 110.11 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -110.42 -16.87 13.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.7 -174.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -88.68 130.27 45.76 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.456 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -88.26 30.12 0.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.825 2.35 . . . . 0.0 111.514 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.6 p . . . . . 0 C--O 1.249 1.076 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.838 -178.202 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.3 pp . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 120.665 0.269 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -144.71 127.3 16.08 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.0 tp -50.95 -62.5 1.57 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -168.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.1 mm -59.06 -30.17 43.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.981 -172.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -78.4 -27.52 46.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.27 0.557 . . . . 0.0 109.806 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.34 -31.5 26.76 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.913 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 6.4 t -58.41 -55.05 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.151 172.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.5 mtp85 -63.31 -41.45 98.93 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.444 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.502 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . -71.08 -6.69 61.13 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.779 176.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.596 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 5.0 t80 -89.13 -59.57 2.19 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.76 -0.22 . . . . 0.0 110.468 176.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.551 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 49.1 p-90 -81.58 -34.0 31.28 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -174.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.53 -28.23 64.77 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.342 0.591 . . . . 0.0 109.995 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 9' ' ' GLY . 0.9 OUTLIER -90.61 -9.28 47.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.76 179.09 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.596 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -94.38 -56.14 2.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.259 -176.121 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 11' ' ' TRP . 70.6 mmtt -63.71 -30.82 71.87 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.036 -172.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 16' ' ' VAL . 2.1 p -63.53 113.81 11.02 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.024 175.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -69.46 116.84 4.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.92 1.746 . . . . 0.0 110.628 174.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 pt -111.48 31.72 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.516 0.674 . . . . 0.0 111.788 -174.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm -101.53 -30.78 11.21 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.097 174.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -75.3 148.02 83.23 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.104 174.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.86 47.95 2.49 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.468 2.112 . . . . 0.0 111.424 171.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 C--O 1.252 1.184 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.834 -176.937 . . . . . . . . 0 0 . 1 stop_ save_